ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001433.1|Argimycin_1 # 1 # 1083 # -1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.770	BGC0001433.1|Argimycin_1 	1	1083	-	Loose	400	40.4318	vanR gene in vanG cluster	32.81	3002926	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGCCGACGACGACCGCGGCCCGGGGCGTCCCGGGCACCACGGTCCTCACCGCCGACGAACGCGAGGTGCTCTACGCACTCGGATGCGGCCTGGGGGACGCCGAGATCGCCGACGCCCTCGCCCTGCCCGCGCACGTGGTGGCCGAGCGGATCAGCCGCGTCCTGGGAAAGCTGGGGCTGAGCGACCGGGCCGCCGCCGTCGTGCACGCCTTCGACTGCGGTCTGGTCGTACCGGGACAGGGCCCGCGCAGGCCGACGCGGACGCCGGGGAGCACCGCGGTGCGGCGGACGGGCACCGCGTCCGGTCCCTGGCTCCGGGTGTCGCTGCTCGGCCCGTTGCGGACGAGCCTCGCGGGGCGGCCCGTGGACCTCGGCCCCCTGCGGCAGCAGGCCGTGCTGGCGGCGCTGGCCCTGAGCGCGGGCCGCCCCGTCAGCCGACGGCGGCTGCTGGACGACGTCTGGGGCAGGGAGATGCCGGACGGCAACGTCGTCCCGGTCTACGTGTACCGGCTGCGCAAGAGCCTGCGTCTCGGGGAGCGCCCGGACCCGGTGATCCGGCGCGACCGGTACGGCTACGCACTGCCCCGCGGTGTCGCCGAGGTGGACGTGCTGTGCATGGAGGACCTCGTCACCCGGTCGGGGGAGGCCGAACGCGCCGGCGACCTGTCCGAGGCCGTGCGGCTGTGCGCCCGGGCCTTGGAGCTGTTCCGCGGTGAGCCGTTGGCCGGACTGCCCGGCCCGCTGGCCGAGTCGGAGCGGCTGCGGCTCACCGGACGCAGGGTCGCCCTGGCGCAGCGGAAGGCGGGCTGGCAGCTGACGCTCGGCCGGCACGCCGAGGTGATCGCCGAACTGTCCGCCCTGACCCGGGAGGAACCGCTGAACGAACCGGTCGCCGCGACGCTGATGCACGCGCTGCGGCGCGGCGACCGGAGGGCCGAGGCACTGGCCGTCTTCGACCGCACCGCGCGGCGCCTGGCCGACGACCTGGGGGTGGCGCCGGGCGACGTGCTGGTGAGGGCACGGCGGGCGGTCCTGCGAGGGGACGGCACCGGCACCGGCCGCGTCCGGGCGGGCGCGGCGTGA	MPTTTAARGVPGTTVLTADEREVLYALGCGLGDAEIADALALPAHVVAERISRVLGKLGLSDRAAAVVHAFDCGLVVPGQGPRRPTRTPGSTAVRRTGTASGPWLRVSLLGPLRTSLAGRPVDLGPLRQQAVLAALALSAGRPVSRRRLLDDVWGREMPDGNVVPVYVYRLRKSLRLGERPDPVIRRDRYGYALPRGVAEVDVLCMEDLVTRSGEAERAGDLSEAVRLCARALELFRGEPLAGLPGPLAESERLRLTGRRVALAQRKAGWQLTLGRHAEVIAELSALTREEPLNEPVAATLMHALRRGDRRAEALAVFDRTARRLADDLGVAPGDVLVRARRAVLRGDGTGTGRVRAGAA	MNEKILIVDDEKEIADLIELYLKNDGYKVYKFYNGIDALKCVESEKMDLAILDVMLPDVDGFHICQKIRERYFYPIIMLTAKVEDADKIMGLTIGADDYITKPFNPLEVAARVKTQLRRYVCYNNAADIEKENVLVTEYDINGLVINKNTHKCTLYGKAVTLTPIEFSVLWYLCENRGKVISSEELFENVWGEKFLDNNNTVMAHIGRLREKLKEPARNPKFIKTVWGVGYTIEE	153.19	gnl|BL_ORD_ID|1523|hsp_num:0	1635			453	642	vancomycin
BGC0001433.1|Argimycin_2 # 1266 # 3587 # 1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.746	BGC0001433.1|Argimycin_2 	1266	3587	+	Loose	950	30.8018	msrC	25.21	3002819	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic; streptogramin B antibiotic	antibiotic target protection	msr-type ABC-F protein	GTGGCCAGTGAGTTCGGCACGGTCCTGCGACGACTGCGCGAGAAGGCGGGGCTGACCCAGGAGGAGCTGGAGCGGCGTTCCGGCATCAGCGTGAGCACCATCGGCGGTCTGGAGAACGGCAGGCACAGGCGTGGCAATCCGCGGATGACCACGGTGCGGAGCCTGGCGGACGGGCTCGCCCTGGACCGCGAGGACCGCGAGGAGTTACTGCGCGCCGCCGTCCCGGGGCGCCCGGACGGCGGCTCGGACACCACCGGTGGGCCGGGGACGCGGGAACAGACGTCCGAGCCCCCTGCCGCGTCACCGCAGGCACCGCCGCCGTCGTCGTCCGCGGCGCACCACGCGCTGGCCGACGCGGCCGAACAGCTCGCGAAGGCGGTGGCCGCCCGCTGGCAGCGCGAGGAGGAACAGCGCCGGATCCAGGACCCCTACCCGCTGCCGGTCCGCTGGAAGGCCGCCTCCGAGGCGCTCACCGACCACTGGGCCAACATCCGCCGCATCCCGCCGGGGGCCCCGAGCGGCCCCCTGGACCTGGACGGCCGGCTGGAGGAGATCGCGCAGACCTACCGGAGCGTCCCCTCCGGGCGGCTGGTGGTCCTCGGCAGGTCCGGCTCCGGGAAGACGGTCCTGACCCTGCGCTTCGTCCTCGACCACCTGAGGACGCGGACGCCGGCCGAGCCCGTCCCGGTGATCTTCAGCATCGGCGCCTGGGACCCCACCGCCCTCACCCTGCGGGACTGGCTGACCGAGCGGCTGACGCGCGACCACCCCGGTACGGCCGCCCGGGGACCGGGCGGGGTGAGCCTGGCGGCCGCGCTGGTCGACTCCGGCCGCGTCCTGCCGGTGCTGGACGGGTTCGACGAGATGGCCGACGGCCTGCGGCGCCCCGCGCTCGAGGCCCTCAACGCCACCACCCTCCCCCTGCTGCTCACCAGCCGCCCCGCCGAGTACGCCGCCGCGGTGGCGGAGACCGACGTCCTGACCTCCGCCGCGCCGGTCGAACTCGTCGACCTCACCCTCGACGACCTGGACCACTACCTGCCCCGCACCACCCGCAAGACCGACCGCGCGGACCCCGCGGCGGGCGCCTGGGACTCCGTGCTGAAGCACCTGCGCGAGCCGTCGCCGGACGGGGCGGCGGCCCCGCTCGCCACCGTCCTGTCGACCCCGCTGATGGTGGCGCTCGCCCGCACCGTCTACAGCGACACCCCGGACCACGATCCGGCCGCCCTGCTCGACACCGAGAGGTTCGCCAGTGCACAGGAGCTGGAGGAACACCTGCTCGACGACTTCCTCCCCACCGTCTACCGCCGGCCCGGTCCGGGTCCGCGCGCGTGGGACCCGGACCGCGCCCAGCGGTGGCTCGGCCACCTCGCCCACCACCTGACGGAGCGCGGAACGCCCGACCTGGCCTGGTGGCGGCTCGGCGACGGCCTGCGCGCCTCCACCCGCGTCCTGGTCACCGCCCTCGTCACCGGAGTGGTCATCGGAGCCCTCGACGTCGTCCCCGCCCTCTTCTACCTCCCGCTCCCCCCGAGCCTTGTGGACGCGGCATCCGTCGGACTCCTGGCAGGCCTGCTGTTCGGGGCCGTGCACTGGCTCGCGTACACGGTCCTGGGCAAGGCCGTCGCACCGTCCGCCGTGCGCCTGCGGATCCGGGGCCGGGCCGGTCCGCCCCGGTGGACGGCCGGCCCGCGGCTGGTGCTGGGCACGCTGGCCGGCACGGCCTTCGGCTGCATGTACGGATTCGCGATCGGCCTGGTGAACGCCTACCGCTGGCAGGCCGGGCTCTCGGCCGCGCTGCAGACCGGACTCGTGAACGCGATCGTCCTGGGCCTGGCCTTCGGCGGCGCCGCCGGACTCACCTTCTGCCTCCTCGGCCTCCTCGAGGCCCCCCTCGACATCGCATCCGCCGTCAGCCCGCGCAGTGTCCTGAACGCCGACCGGCGGACAACCCTCATCCAGCTGGCCATCTGGGCACCGGTGTTCGGCGTGACGGTCGGACTCGGGGTCGGGGTGGTGGTCGACCTGCTGCAGGGGCATCTGGGCCTGCTGATCATGGATACCGCGGGCCTCATCACGATAGGCGCCGTCAGCGGTGTCGGGGGCGCTCTCGGCTACACCCTGAGCATGACCGCCTGGGGCCAGTGGTGCGTGCTCTCCCGCCTCTGGCTGCCGTTGACCGGGCGTCTCCCCTGGGCCGTCGTCGCCTTCCTCGACGACGCCTACCGGCGCGGCGTCCTGCGCCGGGCCGGCGCGGTCTACCAGTTCCGCCACGCCCGGCTGCAGAGCCATCTCGCCCGGGCCCACCGACGCGGATGA	MASEFGTVLRRLREKAGLTQEELERRSGISVSTIGGLENGRHRRGNPRMTTVRSLADGLALDREDREELLRAAVPGRPDGGSDTTGGPGTREQTSEPPAASPQAPPPSSSAAHHALADAAEQLAKAVAARWQREEEQRRIQDPYPLPVRWKAASEALTDHWANIRRIPPGAPSGPLDLDGRLEEIAQTYRSVPSGRLVVLGRSGSGKTVLTLRFVLDHLRTRTPAEPVPVIFSIGAWDPTALTLRDWLTERLTRDHPGTAARGPGGVSLAAALVDSGRVLPVLDGFDEMADGLRRPALEALNATTLPLLLTSRPAEYAAAVAETDVLTSAAPVELVDLTLDDLDHYLPRTTRKTDRADPAAGAWDSVLKHLREPSPDGAAAPLATVLSTPLMVALARTVYSDTPDHDPAALLDTERFASAQELEEHLLDDFLPTVYRRPGPGPRAWDPDRAQRWLGHLAHHLTERGTPDLAWWRLGDGLRASTRVLVTALVTGVVIGALDVVPALFYLPLPPSLVDAASVGLLAGLLFGAVHWLAYTVLGKAVAPSAVRLRIRGRAGPPRWTAGPRLVLGTLAGTAFGCMYGFAIGLVNAYRWQAGLSAALQTGLVNAIVLGLAFGGAAGLTFCLLGLLEAPLDIASAVSPRSVLNADRRTTLIQLAIWAPVFGVTVGLGVGVVVDLLQGHLGLLIMDTAGLITIGAVSGVGGALGYTLSMTAWGQWCVLSRLWLPLTGRLPWAVVAFLDDAYRRGVLRRAGAVYQFRHARLQSHLARAHRRG	MENLAVNITNLQVRFGNQLELSIDSLRVYQQDRIGIIGENGVGKTTLLKLIVGELIPNQGKIQTEITFNYLPQLTYLAEAKDLNLELASHFQLKLEETSERKWSGGEERKIELIRLLSSYEQGMLLDEPTTHLDRKSMDRLIEELRYYYGTLIFVSHDRYFLDELATKVWEVKDGEIREFPENYSAYLTQRELEKKTQLREAESIMKEKKRLEKSIQEKKKQAEKLEKVSSKKKKQQIRPDRLSSSKQKDSVQKAIQKNTKTLERRLQKIGETTKPQQMKQIRFPVPKSLELHNRYPIMGQNIQLERSGRTLLINSDFQFSLGKKIAIVGENGSGKTTLLEHIRKQGEGILLSPKVSFQVYQQKDYQMTSEESVIRFVMRQTEFSESLVRSLLNHLGFAQETLTKPLCTLSGGEATRLTIALLFTKPSNVLLLDEPTNFIDVATIEALEQLMQVYPGTILFTSHDSYFVERTADEVYEIKGQKIKKVLTRNF	157.11	gnl|BL_ORD_ID|1891|hsp_num:0	2054			729	1038	erythromycin; quinupristin
BGC0001433.1|Argimycin_3 # 3688 # 4452 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.732	BGC0001433.1|Argimycin_3 	3688	4452	+	Loose	2090	31.9574	mdsB	29.31	3000790	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCGAAGACCAGCCGACTCGCCCGCCGTGCCAGGGCCGTCGCCCTCGCGACGGTGCTGGCGGCCGCCGCCGCCCTCACGCCCGCCGTCGCCCACGCCGAGGAGGCGCCGCACCACTACTACGTCGAACTCGGCGGCACCGGCTCCGCGGCGGACGCGCCCGGCTGCACCATCACGTTCGGCTACGCCAACCGGTACTTGGAGGGCGGCACGCCCGTCCCCGTCTGCTACCCGGCCTCCGCCGGCCCCTGGCTCAACGGCCGCAACGCGCCGGACCTGTTCGCGCCGAGCTACGACAGCAGCGTCGCCCAGGGCTACACCAACCTCCTGGCCGCCGTCGAGAAGACCCACCGCGAGGACCCCACCGCACGGCTGACGATCGTCGGCTACTCCCAGGGCGCGCAGGCCGCCGACGCGGTGCTGGAGACCATCGCGTCGGGTGCCACGGACATCCCGCGGGAACTGGTCAACGGCATGCTGTACGCCGACCCGAAGCAGCCCGGCACCGGTATGTGGGCCAAGGTCCCCCAGGGCGTGGGCGCCCTCGGCTTCACGTCCGCGGGACCCGGCCCCGAGAGGTTCGCGGGCGTTCCGGTCGCCCGCTTCTGCATCCGCGGCGACCTGGCCTGTGACGCCACGACGCCCGTGGCCGCCTTCGACTTCTTCCTCACCGACACGCACGGGCGCTACGTCCTGGACGGGAACGTCATGACCCGGACCATCGCCCAGGACGGCCTCGACGGGACCTTCTGGTACGAGGCGTGA	MPKTSRLARRARAVALATVLAAAAALTPAVAHAEEAPHHYYVELGGTGSAADAPGCTITFGYANRYLEGGTPVPVCYPASAGPWLNGRNAPDLFAPSYDSSVAQGYTNLLAAVEKTHREDPTARLTIVGYSQGAQAADAVLETIASGATDIPRELVNGMLYADPKQPGTGMWAKVPQGVGALGFTSAGPGPERFAGVPVARFCIRGDLACDATTPVAAFDFFLTDTHGRYVLDGNVMTRTIAQDGLDGTFWYEA	MKFTHFFIARPIFAIVLSLLMLLAGAIAFLKLPLSEYPAVTPPTVQVSASYPGANPQVIADTVAAPLEQVINGVDGMLYMNTQMAIDGRMVISIAFEQGTDPDMAQIQVQNRVSRALPRLPEEVQRIGVVTEKTSPDMLMVVHLVSPQKRYDSLYLSNFAIRQVRDELARLPGVGDVLVWGAGEYAMRVWLDPAKIANRGLTASDIVTALREQNVQVAAGSVGQQPEASAAFQMTVNTLGRLTSEEQFGEIVVKIGADGEVTRLRDVARVTLGADAYTLRSLLNGEAAPALQIIQSPGANAIDVSNAIRGKMDELQQNFPQDIEYRIAYDPTVFVRASLQSVAITLLEALVLVVLVVVMFLQTWRASIIPLVAVPVSLVGTFALMHLFGFSLNTLSLFGLVLSIGIVVDDAIVVVENVERHISQGKSPGEAAKKAMDEVTGPILSITSVLTAVFIPSAFLAGLQGEFYRQFALTIAISTILSAINSLTLSPALAAILLRPHHDTAKADWLTRLMGTVTGGFFHRFNRFFDSASNRYVSAVRRAVRGSVIVMVLYAGFVGLTWLGFHQVPNGFVPAQDKYYLVGIAQLPSGASLDRTEAVVKQMSAIALAEPGVESVVVFPGLSVNGPVNVPNSALMFAMLKPFDEREDPSLSANAIAGKLMHKFSHIPDGFIGIFPPPPVPGLGATGGFKLQIEDRAELGFEAMTKVQSEIMSKAMQTPELANMLASFQTNAPQLQVDIDRVKAKSMGVSLTDIFETLQINLGSLYVNDFNRFGRAWRVMAQADAPFRMQQEDIGLLKVRNAKGEMIPLSAFVTIMRQSGPDRIIHYNGFPSVDISGGPAPGFSSGQATDAIEKIVRETLPEGMVFEWTDLVYQEKQAGNSALAIFALAVLLAFLILAAQYNSWSLPFAVLLIAPMSLLSAIVGVWVSGGDNNIFTQIGFVVLVGLAAKNAILIVEFARAKEHDGADPLTAVLEASRLRLRPILMTSFAFIAGVVPLVLATGAGAEMRHAMGIAVFAGMLGVTLFGLLLTPVFYVVVRRMALKRENRVDSHDQQA	24.08	gnl|BL_ORD_ID|1269|hsp_num:0	1385			1413	1761	chloramphenicol
BGC0001433.1|Argimycin_5 # 7867 # 9318 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.709	BGC0001433.1|Argimycin_5 	7867	9318	-	Loose	600	32.7278	Streptomyces venezuelae rox	50.0	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGAAGCCCAAGAAAGAGACATTCTTCGGGGGAGCGCGCACCTCGCGTCGCGCGATACTCAAGGCCGGCGCCGCCACGGGGGCGTCGGTCGCCGTCGGCGCCGCCTCCGTCCGCCCCGCCTTCGCGGCCGGGACGACCGAGGCCGGCCGCAGCTACGACGCGATCGTGATCGGCGGCGGCTTCGCCGGCGTGTCCGCCGCGCGGGAGCTCAAGGCGAAGGGCAAGCGCACGCTGATCCTCGAAGCCCGCAACCGCGTCGGCGGCCGGGCCTGGTCGAGCACGTTCTCGGGACTGCCGATCGAGTTCGGCGCGACCTGGATCCACCCCAGCCAGACACTGATCTGGAACGAGGTCCAGCGCCTGGGCATCGCCAGGGTGGACGACCCCAACCCGGACTTCGCGGTGTTCGCCACGGAGTCCGGCGGCTACGCCAAGCAGGAACTGACCTTCCTCGACCAGCAGGACGCCCTCCTGCGGAGGTTCGTCGAGGGCGCCGAGACCTACCTGCCGCGCGCCTACGACCCCTTCTACCGCGAGGACCTGCTGGTCGACCTCGACAAGCTGACCCTCGGCGACCGGGCGCGCCAACTGCGTCTTTCCACCCTGGAGATGAACTGGGTCAGCGCCACCACCGGCGCGTACGGCGGCGGCTTCGAGCGCGGCGCGCTCACCCAGCTCGCCCACTGGTGGGCGCTGTGCGGCTACAACACGGAGACGTTCCACGGCATCAACGTCACCCGCCCCGTGGGCGGGATGAGCAACGTCATCTCCCGGATGCTCGCCGAGTCCGGCGCCTCCGTCGTGTACAACGCGCCCGTCACCAAGGTCACCGACAGCGGCTCCCGGGTCCAGGTGACGGCGAACGGCGTGGTGTACGACGCCGCGGCCGTGGTGGTGGCCGTCCCCGTGAACACCTGGAACTCCATCAACTTCGCCTCCGGCCTGCCGGCCGAGTTCTCCCGGCTGAGCACCCAGACCGTCGGCGTGCCCACCGCCAAGAAGGTCTTCATCCAGGTCCAGGGCGACATCGGCCGCCCGCTCATGAACGGCAAGAGCGGCGCGATGCTCGACCTGGTCCTCACGCACGCCGACAAGTCGGCCCAGGGCACGGTGCTCATCGGCTTCAGCGTCAACCCGAACCTGGACGTCACCAGCGTGTCGCAGGTGCAGAGCGCCATCAGCGAGCTGCTCCCGGGCACCAAGGTGCTCTCCGTCAAGGGCCACGACTGGGGCAAGGACGCCTACGCCAAGGGCGGTTGGACCTTCCGGACCCCCGGTCAGCTGCTCGGTTCGCTGCGCGTCGTCCGGCAGCCGCACGGCCGCCTGGTCTTCGCGGGCAGCGACATCGCCACCGGCTGGGGCGGCTATGTGGACGGCGCCATCGAGACCGGCATCCGGGCCGCCGGCCTCGCGGCCGGCCTGACCGCCGCCGCGGCCTCCGCGACGAGCTGA	MKPKKETFFGGARTSRRAILKAGAATGASVAVGAASVRPAFAAGTTEAGRSYDAIVIGGGFAGVSAARELKAKGKRTLILEARNRVGGRAWSSTFSGLPIEFGATWIHPSQTLIWNEVQRLGIARVDDPNPDFAVFATESGGYAKQELTFLDQQDALLRRFVEGAETYLPRAYDPFYREDLLVDLDKLTLGDRARQLRLSTLEMNWVSATTGAYGGGFERGALTQLAHWWALCGYNTETFHGINVTRPVGGMSNVISRMLAESGASVVYNAPVTKVTDSGSRVQVTANGVVYDAAAVVVAVPVNTWNSINFASGLPAEFSRLSTQTVGVPTAKKVFIQVQGDIGRPLMNGKSGAMLDLVLTHADKSAQGTVLIGFSVNPNLDVTSVSQVQSAISELLPGTKVLSVKGHDWGKDAYAKGGWTFRTPGQLLGSLRVVRQPHGRLVFAGSDIATGWGGYVDGAIETGIRAAGLAAGLTAAAASATS	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	101.47	gnl|BL_ORD_ID|4833|hsp_num:0	5820			3	93	rifampin; rifaximin; rifapentine
BGC0001433.1|Argimycin_6 # 9694 # 10872 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.704	BGC0001433.1|Argimycin_6 	9694	10872	+	Loose	760	29.261	macA	27.59	3000533	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGCCGTCAGGTCCACCGAAGCGGAAAACATCCTCAAGGCGGTCCGGGAAATCGTCCCGACCCTGCGGGCGAACGGCGTGGCCTCCGAGGACCAGCGCTGGATAGTCCAGGAGAACATCGACCTCCTGGAGAAGGCCGGCGTCTTCCGGATCGCCGTGCCCAAGCGCTTCGGCGGCCTGGACCTGCCGCTGAAGGAGCAGGTCGAGATCATCACCGAGATCTCCCGGGGCTGCGGCTCCACCGGCTGGGTGGCCGTCGCCTGGATCTCCAGCGCCTGGATGGCCACGCTGTACCCGCTCGAGGCCCAGGAGGAGATCTTCAAGGGCGGCTCGGTGCGCATCTCCGGCGGTTTCACCCCGACCGCGAAGATGGTCCCCGCCGAGGGCGGCTACCTCCTCAACGGCGCCTGGCGCTTCAACTCCGGTGTCCGCGGCGCCCACTGGGACCTGCTCGCCGCCGAGCTGGAGCACGCCGACGGCACCGTCGAAGAGGTCTACGCCATGGTCCCGGTGGACCAGCTGACGATCGCCGACGACTGGCACGTCTCGGCCGCCATCGCCACCGGCAGCTCGACGTCCAGCGCCACGGACCTCTTCGTCCCCGCCCACCGGGTCGTCACCCTGGAGGCCGCCGTCCTCGGCACCAGCGGCGGCGGTGCCGTCACCGGCTCCCAGGGCCGCGACTACAGCCTGATCAGCTTCGTCGTCGCCGAGTCCGTCGCCGCCTACATCGGCATGGCGCGTGGCGCGTACGAGGACCTCGTCGCCACGGTCAAGGGCAAGCCGCTCGCGTACAGCAACGTCACCGACCAGGCGCAGCACCCGCTGACCCAGATCCAGATCGCGCTGGCCCACAGCAAGATCGAGGCCGCCGAGGCGCTCGCCGAGACCTACCTCGGCTTCCTCCAGGAGCGCGCCGACGCCGGCGAGCAGCCGACCTGGGAGGAGAAGGCGGAGGTGCGCGGCAAGGCCGGCGCCGCGATCCTGCTCACCCAGGAGGCCCTGGAGGCACTCCACTCCATCAGCGGCGCCGGCTCGCTCTCCCGCAAGGCGCCCTTCCAGCGCTTCTACCGGGACCTGCAGGGCCTGTCCCGGCACGGTCTGATGGCCCCGAACATGGGCCTCGAGGTGTACGGCCGCACGCTGCTCGGCCTCGACCCCGACAGCCTTTTCCTGTAA	MAVRSTEAENILKAVREIVPTLRANGVASEDQRWIVQENIDLLEKAGVFRIAVPKRFGGLDLPLKEQVEIITEISRGCGSTGWVAVAWISSAWMATLYPLEAQEEIFKGGSVRISGGFTPTAKMVPAEGGYLLNGAWRFNSGVRGAHWDLLAAELEHADGTVEEVYAMVPVDQLTIADDWHVSAAIATGSSTSSATDLFVPAHRVVTLEAAVLGTSGGGAVTGSQGRDYSLISFVVAESVAAYIGMARGAYEDLVATVKGKPLAYSNVTDQAQHPLTQIQIALAHSKIEAAEALAETYLGFLQERADAGEQPTWEEKAEVRGKAGAAILLTQEALEALHSISGAGSLSRKAPFQRFYRDLQGLSRHGLMAPNMGLEVYGRTLLGLDPDSLFL	MAKMMKWSAVAAVAAAAVWGGWHYLKPEPQAAYITETVRRGGISRTVSATGEISPSNLVSVGAQASGQIKKLYVKLGQQVKKGDLIAEINSTTQTNTLNMEKSKLETYQAKLVSAQIALGSAEKKYKRQTALWKDDATSKEDLESAQDALAAAKANVAELKALIRQSKISINTAESDLGYTRITATMDGTVVAIPVEEGQTVNAAQSTPTIVQLANLDMMLNKMQIAEGDITKVKAGQDISFTILSEPDTPIKAKLDSVDPGLTTMSSGGYNSSTDTASNAVYYYARSFVPNPDGKLATGMTTQNTVEIDGVKNVLLIPSLTVKNRGGKAFVRVLGADGKAAEREIRTGMRDSMNTEVKSGLKEGDKVVISEITAAEQQESGERALGGPPRR	100.00	gnl|BL_ORD_ID|1546|hsp_num:0	1680			534	708	erythromycin
BGC0001433.1|Argimycin_7 # 10912 # 11808 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.670	BGC0001433.1|Argimycin_7 	10912	11808	+	Loose	750	26.5646	tet(X6)	32.56	3005056	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGAGGAGCAAGTCAATGTCGAACACGAACCAGGGTCCGGTGACCGTTCTCGGTCTGGGAATGATGGGCGCCGCCCTGGCCACCGCCTTTGTGAAGAACGGCAATCCGACCACCGTGTGGAACCGTTCCGCTGACAAGGCGGACGCGCTCGTCGAGCAGGGCGCCGTCTTCGCCGCGGACATCAAGCAGGCGATCGAGGCCAGCCCGGTCGTCGTGGCGTGCGTCTCCACCTACGAGGTGCTGAACGACCTGTTCGCCGGTGCCGCCGACGAGCTGAAGGGCAAGGTGGTCATCAACCTCACCTCGGGTACCCCCGAGGACGCCCGCGCCCTCGCCGTCTGGGCCGAGCAGAACGGCGTGCGCTACCTGGACGGCGCCATCATGGCCGTCCCGCAGATGATCGGCCTGCCCCAGGCCCTGATCTTCTACGCCGGTGCCCAGGAGGTGTACGCCGAGCACGAGGAGCTGCTGAAGCCGCTCGCGGGCACGAACGTGTACCTGGGTGCGGACACCGGTGTCGCGATGATCTACGACCTCGGTCTGCTGTCGCTGCTGTGGTCGAGCCTCGCGGGTTACTTCCACGCCGTGGCCCTCGTCAACTCGGCCGGCGTCTCGGCGGAGGCCTTCACCCCGTTCGCCCTGACCTGGATCGAGCACGTCATCACCCCGTCGATCCCGCAGAGCGCCAAGGAGATCGACTCGGCGAGCTTCGACACCGAGATCTCCAGCCTCGGCGTCAACAAGGCCGCGATCGAGCACCTGGTCGCCACGAGCAAGCAGCTCGGCATCAACAGCGACTTCTCGGCCGCCATCCAGGCGCTGATCGAGCGTCGCGTCGAGCAGGGTCACGCCGGTCACAGCCTGGCCAGCCTGGTCGAGGCGTTCAAGCAGGGCTGA	MRSKSMSNTNQGPVTVLGLGMMGAALATAFVKNGNPTTVWNRSADKADALVEQGAVFAADIKQAIEASPVVVACVSTYEVLNDLFAGAADELKGKVVINLTSGTPEDARALAVWAEQNGVRYLDGAIMAVPQMIGLPQALIFYAGAQEVYAEHEELLKPLAGTNVYLGADTGVAMIYDLGLLSLLWSSLAGYFHAVALVNSAGVSAEAFTPFALTWIEHVITPSIPQSAKEIDSASFDTEISSLGVNKAAIEHLVATSKQLGINSDFSAAIQALIERRVEQGHAGHSLASLVEAFKQG	MTLLKHKKITIIGAGPVGLTMARLLQQNGVDITVYERDKDQDARIFGGTLDLHRDSGQEAMKRAGLLQTYYDLALPMGVNIVDEKGNILTTKNVRPENRFDNPEINRNDLRTILLNSLQNDTVIWDRKLVTLEPDKEKWILTFEDKSSETADLVIIANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTPDEWKSKTRVDFQDRNSVVDFLLKKFSDWDERYKELIRLTSSFVGLATRIFPLDKSWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFAYGREAQAESIINETEMFSLDFSFQKLMNL	78.84	gnl|BL_ORD_ID|4802|hsp_num:0	3797			24	150	tetracycline; minocycline; oxytetracycline
BGC0001433.1|Argimycin_8 # 12579 # 14144 # -1 # ID=1_8;partial=00;start_type=TTG;rbs_motif=CCCCC;rbs_spacer=15bp;gc_cont=0.735	BGC0001433.1|Argimycin_8 	12579	14144	-	Loose	900	26.9498	lsaD	37.14	3005121	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; pleuromutilin antibiotic	antibiotic target protection	lsa-type ABC-F protein	TTGGCCGAACCCCATCTGGGGGCCGTGCTGGCCTCCGCCGGCCTGGACGCCGAATACGTCCGGGCCGAGGGGAACCTTCTCTACCAGCGGGGCGAGGACGGCCGCGAGGTCGCCGTCGTGGACTACGCGGGGGGATACGGTTCGCTGCTGCTGGGCCACAACAACCCCGCGATCACCGCGTACGCGAAGGAGCTGCTGGAGAGCGGCGTCCCGGTGCACGCGCAGTTCTCCCTGCACCCGGAGGCAGCCGAGCTGGCGCTCGCCCTGGACCGGATCGTCCGCCGCGAGACCGGTGACGACGAGCCGTTCTTCGCCGTCTTCGCCAACACCGGCGCCGAGGCCAACGAGGCCGCCCTCAAGCATGCCGAGATGGACCGGGGCGCCCGCCTCGGCGCGCTCCTGGAGTCCGTCCGCGACGGCCTCGACGCGGCGCGCGCGGCCGTGCGGGACGGTTCGGCGACGGTGCCCGCCGAGGTCCTCGCCCGCTTCGGCGTGGCCGCGGACGGCCCGGCCCCCGCCGCGCTGGACGAGCTGATCGACCGGCTCGCCGCCCACAACGAGGACCGGGCCGGGCGCCCCCCGGTCTTCCTCACCCCGGAGGGCTCCTTCCACGGCAAGCTGGTCGGCACGGTCCAGCTCACCCACAACGAGGGCTACCGCGCCCCGTTCGGGGCGCTGGCCGCGCAGGCGCGGTTCGTCCCGCTCGGCCAGCCGGGCGCCCTGCGCAAGATCGTCGACGAGGAGCGCGCCACGCTCCTCGGCCTGACCCTGGAGGACGGCCGGGTCCGGCTGTCGGAGCACGAGGCGCCCGTCGTCTGCGCGTTCGTCCTGGAGCCGATCCAGGGCGAGGGCGGCATCCGCGAGCTGTCGGCGGAATTCGTCCGGGAGGTCCAGGAGGTCTGCGCGGAGATCGGCGCACCGGTCATCGTGGACGAGATCCAGAGCGGCATGGGACGCACGGGTGACTTCCTGGCCGGCACGCGCCTGGGGCTGCGCGGCGACTACTACACCCTCGCCAAGAGCCTGGGCGGCGGCCTCGCCAAGATCTCGGTGCTGCTGGTGCGCGCCTCGCGCTACCGCGGCGAGTTCGAGCTGATCCACAGCTCGACCTTCGCCAAGGACGGCTTCTCCAACCGCATCGCCCTGAAGGTCCTCCAGCTCCTGGAGGCCGACGACGGCGCCGCCTACCGCAGGGCCGCCGAACGGGGCGAGCGGCTGCTGGCCATGCTGGACTCCGTGCGGGAGGACTTCCCCGAGGTCGTCAAGGACGTCCGCGGCCGCGGCCTGATGCTCGGTCTGGAGTTCCACGACCAGTCCGAAGCGCCGGTGCCCCCGATCGCCGAGGCGGCCCGGTCCGGACTGTTCGGCTACCTGGTCGCGGGCCACCTGCTGCGCGGCCACCGGGTCCGTACGTTCCCGACCGCGAGCGCCCCCGACACCCTGCGCTTCGAGCCGTCCGTCCTGCTGTCGGACGACGAGATCGCCTGGCTGGAGACGGCCCTGCGCGACACCTGCGACATCATCCGGGGCGGCTATCAGCGCCCCCTGGCGCTGCCCGCCGCGTAA	MAEPHLGAVLASAGLDAEYVRAEGNLLYQRGEDGREVAVVDYAGGYGSLLLGHNNPAITAYAKELLESGVPVHAQFSLHPEAAELALALDRIVRRETGDDEPFFAVFANTGAEANEAALKHAEMDRGARLGALLESVRDGLDAARAAVRDGSATVPAEVLARFGVAADGPAPAALDELIDRLAAHNEDRAGRPPVFLTPEGSFHGKLVGTVQLTHNEGYRAPFGALAAQARFVPLGQPGALRKIVDEERATLLGLTLEDGRVRLSEHEAPVVCAFVLEPIQGEGGIRELSAEFVREVQEVCAEIGAPVIVDEIQSGMGRTGDFLAGTRLGLRGDYYTLAKSLGGGLAKISVLLVRASRYRGEFELIHSSTFAKDGFSNRIALKVLQLLEADDGAAYRRAAERGERLLAMLDSVREDFPEVVKDVRGRGLMLGLEFHDQSEAPVPPIAEAARSGLFGYLVAGHLLRGHRVRTFPTASAPDTLRFEPSVLLSDDEIAWLETALRDTCDIIRGGYQRPLALPAA	MSNIKINNLTFGYTDQLIFDNVNINIDDQWKLGLVGRNGRGKTTLLKILLGEVDVHLEIKTNKSFVYFPQTINDKDQLTLFVLQELADFEQWELERELTLMGVDLDTLWRPFNSLSGGEQTKTLLALLFLDEHNYPLIDEPTNHLDKASREKVAAYLSEKKGYILISHDRNFLNKTTDHTLAIERADLQVYAGNFAIYEEEKRLRDLTEKAQDDKLRKEIGRLKQTAREKEAWSRNLEATKSRKKRGFDSETKRVDKGFIGRKAANMMQKSKNLEKRMKEDIADKELLLKNWEEVPGLEMSVLESHQKRLLTVENLAAGFEDFLFEPVSFTLEQGQVLALTGENGRGKSSLMKVLTGEFTGRYVGTFELAHNLVISEVRQLADNRGFLNEFAKKENLELELFLNNLRKLGVERKVFEQKIENMSQGQQRKVELARALSQPAHIYLWDEPLNYLDVFNQEQIIQMIKRSKPSMLVIEHDQYFVDQVADAQIELIKSSV	104.83	gnl|BL_ORD_ID|4773|hsp_num:0	3847			1011	1116	lincomycin; clindamycin; virginiamycin M1; tiamulin
BGC0001433.1|Argimycin_11 # 15515 # 15925 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.691	BGC0001433.1|Argimycin_11 	15515	15925	-	Loose	760	25.7942	macA	35.14	3000533	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGTCGAACACCGCCACGGCCGTCGAGCTTCCCAAGGAGCTCGCGGCGCACCTCGAGAGTTATGTCGCCGCCTTCAACTCGGGTGACGCCGAGCGCGTCAATGCCCACTACACCGAAGCCGGCATCATCGCGTGGGAGAAGGGCAATCCGGTGAGCGGCGCGGACCGCCGGGCCGCCATCGAGGAATTCCTCACCACCATGCGGCCGCACATCGAGACCGATCTGCGGGAGGCGTACGTCACCGGCGACACGGCCCTGCTGGTCGTGGACTGGACCATGGAGATCAACACCGCGAGCGGCGAGGGCCGCGAGAGCCTGCGCGGCGTCGGCCTGGACGTCCTGCGCAAGCAGGCGGACGGCTCGTGGCTGTACGCCGTCGACGACCCGTTCGCCGAGGAGCCGCGCGACTGA	MSNTATAVELPKELAAHLESYVAAFNSGDAERVNAHYTEAGIIAWEKGNPVSGADRRAAIEEFLTTMRPHIETDLREAYVTGDTALLVVDWTMEINTASGEGRESLRGVGLDVLRKQADGSWLYAVDDPFAEEPRD	MAKMMKWSAVAAVAAAAVWGGWHYLKPEPQAAYITETVRRGGISRTVSATGEISPSNLVSVGAQASGQIKKLYVKLGQQVKKGDLIAEINSTTQTNTLNMEKSKLETYQAKLVSAQIALGSAEKKYKRQTALWKDDATSKEDLESAQDALAAAKANVAELKALIRQSKISINTAESDLGYTRITATMDGTVVAIPVEEGQTVNAAQSTPTIVQLANLDMMLNKMQIAEGDITKVKAGQDISFTILSEPDTPIKAKLDSVDPGLTTMSSGGYNSSTDTASNAVYYYARSFVPNPDGKLATGMTTQNTVEIDGVKNVLLIPSLTVKNRGGKAFVRVLGADGKAAEREIRTGMRDSMNTEVKSGLKEGDKVVISEITAAEQQESGERALGGPPRR	34.69	gnl|BL_ORD_ID|1546|hsp_num:0	1680			999	1110	erythromycin
BGC0001433.1|Argimycin_12 # 16207 # 29994 # 1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.757	BGC0001433.1|Argimycin_12 	16207	29994	+	Loose	500	31.187	OXA-526	33.33	3005756	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGACGACCAGCGAGCACGACACCCACGCAGAACCCACCTGGGAGGGCGGCGCGACCGGGGACCGGGCGGAGCCCATTGCTGTCATCGGCATGTCCTGCCGGCTTCCAGGCGCCGACTCCCCCGCCGCGTTCTGGGACCTGCTCACCCGCGGCGCGGACGCCATCACCCCGGTACCGGAGGGGCGTTGGGGCCCGGACGGGCGCTCCCTCGGTGCCGGGCGCGGCGGTTTCCTCGACGCCGTCGACGCGTTCGACGCGCCGTTCTTCGGGATCTCCCCGCGTGAGGCGGCGGCCATGGACCCGCAGCAGCGGCTCGTGCTGGAGCTCGCCTGGGAGACGCTGGAGGACGCCGGCGTCGTCCCCGCCTCCTTGCGCGGCAGCAGGACGGCCGTCTTCGTCGGCGCCCTGCGCGACGACTACACGAGCCTGCTGTACCTGCACGGCGCCGAGGCCGTCACCCAGCACACCATGACCGGCGTCAACCGCGGTGTCATCGCCAACCGGGTCTCGTACCACCTGGGCCTGCACGGTCCGAGCATGACCGTGGACTCCGCCCAGTCGTCCTCGCTGGTGGCCGTCCACCTGGCCTGCGAGAGCCTGCGCGCCGGCGAGGCCGACGGCGCGCTGGTGGCGGGTGTGAACCTCAACCTGCTCGCGGAGAACGTTGTCACCGAGTCCCGCTTCGGGGCGCTGTCGCCCGACGGGACCACCTACACCTTCGACGCCCGCGCCAACGGCTTCGTGCCCGGCGAGGGCGGCGGCATGGTGCTCCTGAAGCCGCTGAGCCGGGCGCGGGCCGACGGGGACCGGATCTACGGCGTCGTCCGCTCCAGTGCCGTCAACAGCGACGGCGCCACCGACGGGCTCACCGTGCCGAGCGCGGCCGCCCAGGAAGCGGTGCTGCGGGAGGCGTACGAGCGCGCCGGGATCGCCCCCGACGAGGTGCAGTACGTCGAACTGCACGGCACCGGCACCCCCGTCGGGGACCCGCTGGAGGCCGCCGCGCTCGGCGCCGCGCTCGGCCGCGGCCGCACGGCCCGCACCGCCCTGCGCGTCGGCTCCGTGAAGACCAACATCGGCCACCTCGAAGGCGCCGCGGGCATCGCCGGCCTGATCAAGACGCTGCTCAGCCTGCACCACCGCAGGCTCCCGGCCAGCCTGAACTTCGAGACCCCCAATCCGCGGATCGCGCCGGACGAGCTCGGGATCGCCGTGCAGCGGGAGCCCTCGGCCTGGCCGGACGAGGACCGGGCGCTGATCGCCGGCGTCAGCTCCTTCGGCATGGGCGGCACCAACGCCCACGTCGTCGTCTCCGAGGCCCCCGCCGACCCCGCCGTCATCTCCGAGGCCCCCGCCGGGCCCGCCGCCGTCGCCGGGCCCGGCGCCCCGGCGGCCGGCGTCCCGCTGCCGTGGATCGTCACCGGCCACGACGAGGACGCGCTGCGGGCCCAGGCCGCGAAGCTGCGGGCCTTCGCCGCCGAGCGCCCCGGTCAGCCGGCCGAGGACACCGGCCGGGCGCTGGCCACCACCCGCACCTTCCTGGGCCACCGCGCCGTCGTCGTCGCCGACGGCCGCGACGCGCTGCTCGCCGGCCTGGACGCGCTCGCCACCGCCACCCCCGCCGCCTCCGTCGTCTCCGGGGTCGCACGGCCCGGCGGGCTGGCCTTCCTCTTCACCGGTCAGGGCGCCCAGCGCACCGGCATGGGCCAGGAGCTGTACGCGGCGTTCCCGGCGTACGCCACCGCCTTCGACGAGGTCGCGGCCCACCTGGACCCGCTGCTGCCGCGCCCGCTCGCCGAGCTCGTCGCCGACGACACGGCGCTGCACGAGACCGGCGCCACCCAGCCCGCGCTGTTCGCCGTCGAGGTCGCCCTCTTCCGCCTCGTCGAGAGCTGGGGGCTGCGGCCCGACCGGCTCGCCGGCCACTCCATCGGCGAGCTGGCCGCGGCCCACGTCGCGGGCGTGTTCTCCCTCGCCGACGCCGCGCGCCTGGTCGCCGCCCGCGCCCTGCTGATGCAGGCGCTGCCCACGGGTGGCGCGATGATCGCCGTGGAGGCCACCGAGGCCGAGGTGCTGCCGCTTCTCGCGGACCACGAGGGCGCGCTCGCCGTCGCCGCCGTCAACGGCCCCCGTTCCGTCGTGCTGTCGGGTGACGCGGACGCGGCCGCGGAGGTGGCCGCCGCGCTGCGGGACCGGGGCCGCCGCACGAAGCGCCTGACCGTCTCGCACGCCTTCCACTCCCCGCACATGGATCCGATGCTGGCGGAGTTCCGCGCGGTCGCGGCCTCGCTCGACTACGCGGAGCCGGTAATTCCGGTCGTCTCCACGGTCACCGGGGAGCCGGTGACCGCCGGGCAGTTCACCTCGCCCGACTACTGGGTCGAACAGGTCCGCCGTCCGGTGCGGTTCCTCGACACCGTCCGTGCCCTGGAGAGCGCCGGCGCGCGCACCTTCCTGGAGCTGGGGCCCGAGGGCGTCCTGTCCTCCCTGGTCGGGGAATGCGCCGCGGACGCCGACGCCGTCGCCGCCGTACCGCTGCTGCGCGCCGGCCGCTCCGAGCCGCTGACCGCGCTGAGCGCGCTGGCCACCGCGTTCACCCGCGGCGCCGAGCCCGGCTGGACCGCCCTGTACGGCGGCCGGCCCGCGCGCCACGTCGAGCTGCCGACGTACGCCTTCCAGCGCCGCCCCCACTGGCCGGCCGGTCTCCGCACGGCCGTCGACCCGTCACGGCCGGCCCCCGCCCCCGAGGCCGCCGTCCCGGCCGCTCCCCCGGCCGCCACCCCCCGCGGCGAACTGGGCCGCCGTCTGGCCGCGCTCGACGGGGCGGAACGCCGGCGCGCCGTCGAGGATCTGCTGCACCCCCACATCGCCGCGGTCCTGGAGTACGAACCGGGCCGGCGCATACCCGACCACACGCCCTTCCGGGACCTCGGCTTCAGCTCCCTGATGGCCACCGAACTGCGCGGCACGCTCGCCCGGGCCACCGGCCTGAAGCTGCCCGGCGGCCTGCTCTTCGACCACCCGACGCCGCGGGCCCTCGCCGAGTTCGTCGAGGCCGAACTCCTCGGCGAGGCCGCGGTCGCGGACGAGACGGCGGACGGGTCGGCGGCGGGCGCCGACGGCGAGGCGATCGCCGTCGTCGCCATGGCCTGCCGCTACCCGGGCGGCGTGGCCTCGCCCGAGGACCTGTGGCGCCTCGTCACCGAGGGCGGCGACGCCGTCGGCGAGTTCCCCACCGACCGCGGCTGGCCCGAGGACCTGTACGACCCGGATCCGGACCGGCCCGGCCGCAGCTCCGTGCGCCACGGCGGGTTCCTGCACGACGCGGGCGACTTCGACGCCGCGTTCTTCGGGATCTCCCCGCGCGAGGCCCTCGCCATGGACCCGCAGCAGCGCCTGCTGCTGGAGACCGCGTGGGAGAGCGTCGAGCGCGCCGGCATCGACCCCGCGCGGCTGCGCGGCACCCGCACCGGCGTCTTCGTCGGCGCCACCGGCCTGGAGTACGGGCCGCGCATGGACGAGGCCCCCGAGTCCGTCCAGGGCGGCGTGCTGACCGGCACCACCACCAGCGTCATGTCCGGCCGCATCGCCTACCAGCTCGGCCTGGTCGGCCCGGCGATCACGGTGGACACGGCCTGCTCCTCCTCCCTGGTCGCCCTGCACCTGGCGATCCGCTCCCTGCGCTCCGGCGAGACCGACCTCGCCCTCGCGGGCGGCGCCACCGTCATGTCCTCGCCGGGCATGTTCGTGGAGTTCTCCCGCCAGCGCGGACTGGCCCCCGACGGCCGCTGCAAGGCCTTCGCCGACGACGCCGACGGCACCGGCTGGTCCGAGGGCGTCGGCCTGCTCCTGCTCGAACGGCTCTCCGACGCGCAGAAGAACGGCCACACCGTCCTCGCCGTGCTGCGGGGCTCCGCCGTCAACCAGGACGGGGCCAGCAACGGCCTGACCGCGCCCAACGGCCCCTCCCAGCAGCGCGTCATCCAGCAGGCGCTGGCCGACTCCGGGCTGAGCCCCGCGGACGTGGACGCCGTCGAGGCCCACGGCACCGGAACCCGTCTCGGCGACCCCATCGAGGCGGAGGCCCTCAAGGCCGTCTACGGCCCCGGACACGACAGCGACCGCCCCCTCCACCTCGGCTCGCTGAAGTCCAACCTCGGCCACACCCAGGCCGCCGCCGGCGTCGGCGGCGTCATCAAGATGGTGCAGGCGATGCGGCACGGCGTGCTGCCCAGAACGCTCCACGTGGACCGGCCGACCAGCCGGGTCGACTGGTCCGACGGCACCGTCGCCCTGCTCACCGAGGAACGCCCGTGGCCCGGGACCGACCGTCCCCGGCGCGCCGCCGTCTCCTCCTTCGGCATCAGCGGCACCAACGCCCACCTCGTCGTCGAGGAGGCGCCGGCCGGCGCCCCGGCCGGCACGGACGGGGAGTCCGCGCGGCCCGGCGGCACCGCCGCCCTCGCCGTCGGACCCGCGCCGTACGTCCTGACCGCCCGCGACCCGGACGCGCTGCGCGAGCAGGCCGCCCGGCTGGCCGCGCACGTCACCGCCTCCGGCACCGGCACCCGCCTCGCCGACCTCGGCTTCTCGCTCGCCACCACCCGCACCGCCTTCGAGCACCGCGCCGTCGTCCTGGCCTCCGACACCGGGGACCTGCTCGCCGGACTGACCGGGCTCGCCGCCGGCACCGGCGCCCCGAACACCGTCACCGGCACCGCGGACACCCCGGGCCGCACCGCGTTCCTGTTCACCGGCCAGGGCGCGCAGCGCGCCGGATCCGGCCGCGAACTGTACGCGGCCCAGCCGGTGTTCGCCGCCGCCCTCGACGAGGTGTGCGCCGCCTTCGACGGTCTGCTGGAGGTGCCCCTGCGCGACGTGCTGTTCGGCGAGGGCGCGGGCGAGGGGCTGATCGACCGCACCGCGTACACCCAGCCGTCGCTGTTCGCCGTCGAGGTGGCCCTCTTCCGGCTGCTGACCCACCACGGACTGACCCCCGACCTGCTCGCCGGGCACTCGATCGGCGAACTCGCCGCCGCCCACGCCGCCGGGGTCCTCTCCCTGGAGGACGCCGCGGTCCTGGTCGCCGCGCGCGGCCGGCTCATGCAGTCCGCACCGGCAGGCGGGGCGATGACCGCCGTCGAGGGCACCGAGGAGGAGATCGCCGCCGGGCTCGCCGGGCAGGAGTCCGCCGTGTCGGTCGCCGCCGTCAACTCCCCCTCGTCCGTGGTGATCTCCGGCGACGCCGAAGCCGTGGAGGAGGCCGCCCGCGGCTGGCGGGAGGCAGGCCGCCGCACGCACCGGCTGACGGTCTCGCACGCCTTCCACTCCCCGCACATGGACGGCGTCCTGGAGGAGTTCCGGGCCGTCGCGGCCGGGCTCACCTTCCACCGCCCGCGCATCCCGATCGTCTCGACGGTGACCGGCGAGATCGCCACCGCCGAGCAGCTCACCTCGCCCGACTACTGGGCGCGGCAGATCCGCGAGACCGTCCGCTTCGCCGCCGCCACCCGGCGCCTCGCGGCCGAGGGGGCCACCGTCCTCGTCGAGGTCGGCCCGGACGCCGTGCTGACGGCGCTGGCCCGGCGCATTCTGGAGGACACCCCGGCGGCCGCGGTCACCGCCGTCCCCGTGCTGCGCGCCGGACGCCCCGAGGCGGAGACCTTCGCCACCGCGGCGGCCGCGGCGTACGCCCAGGGCGCCCCGCTCGACGTCGCCTCCTTCTTCCCCGGCGCGGCCCGCACCGACCTGCCGGTCTACCCCTTCCGGCGCACCCGCTTCTGGCTGAACGCCGCGCCGCGCACCGACGCCCGCAGCCTCGGCCTCGACCCGGCCGAGCACCCGCTGCTGACCACCGCCGTGGAGTTCGCCGAGCGGGAGGACGCGCTGTTCACCAGCCGCCTCTCGCGCGCCGCCCAGCCCTGGCTGGGCGACCACGCGATCGCCGGCACGGTCATCGCACCGGGCACCGCCTTCCTCGAACTCGCCGTCGCGGCGGGCGGGCACGTCGGCGCCCCGCACCTGACGGAGATGACGCTGGAGGCGCCGCTGCCGCTGCCCGAGCGCGGAGCCGTCCGCGTCCAGGTGGCGGTCGGCGCGCCGGACCGGGACGGGCAGCGCCCGTTCACCGTCCACGCGCGCCCGGACACCGCCGACGGCGCCCTGCCCTGGACCCGGCACGCCACCGGGCTGCTCGCCCGGGCCGGCGCGGCGCCCGCCGCCGACGCGGACCTCACCTCCTGGCCCCCGGCCGGCGCCACCGCCGAGAACCTCGACGACGTCTACGACCGGCTGGCCGCGCTCGGCTACGCCTACGGCCCCGCCTTCCGGGCCCTGCGCGCCGTCTGGCGGCGCGGCACCGACCTCTTCGCCGAGGTGGGTCTGCCCGAGGCGCAGACCGGCGGTGCCGCCGCGTACGGACTGCATCCCGCGCTGCTCGACGCCGTACTGCACCCGCTGGTGCTCGACGCGGCCGCGGAGACGGACCCGGCGCACATCCGGCTGCCGTTCGCCTGGAACGACGTCACCCTGCACGCGGCGGGCGCCGCCGAGCTGCGCGCCCGGATCTCGCCCGCCGGCCCCGGGCACGCCGCCATCACCGTCGCCGACGGCACCGGCGCCCCCGTCGCCGACCTGGACCTCGCCCTGCGCGCCGTCCCCCGGGACCGGCTCACGGCGGCGTCGCACACCGGCGCCGGCTCGCTGTTCACCGTGGAATGGAACGAACTGCCCCCGCCCGCACCGGACACCTCCCTGGTGTGGTCCGAGGCAGTCGCCTCCGACGACTCGCTCGACTCCGCCGAGCCGGCCGACGTGGTCGTCCTGCGGGTGCCCGCCGTCCCGGACGGCGCGGACGACCCGCGGCCCACCACCGGCCGGGTGCTGCGCCTCGTCCAGCGGTGGCTGGCCGACGAGCGGTTCGCCGGCTCCCGGCTCGCCCTGGTGACCCGGCGCGCCGTCGCCGCACGGCCCGGCGACGACGTGGACCTCGCGGGCGCGCCCGTGTGGGGCCTGATCCGCTCGGCGCAGTCCGAGCACCCCGACCGCATCGTCCTCATCGACCTCGACGACGACCCGGCGGCGGACTCCCTGCTGCCTGCCGCGCTCGCCGCCGAGGAGCCGCAGCTGGCCGTGCGCGACGGCCGGCTGCACGCGCCCCGGCTCGCCCGCACCCCCCGGGCGGCCGGGGCGCCCACCCCCCGCTTCACCCCGGACGGCACGGTCCTCGTCACCGGCGGCACCGGTGGGCTGGGCGCCCTGTTCGCCCGCCACCTGGTGACCGGGCACGGCGTACGGCACCTGCTGCTGAGCAGCCGCCGGGGCCCCGACGCGCCCGGCGCCGCCGAGCTGGCCGGGGAGCTGACCGCGCTCGGCGCCGAGGTGACCGTCACCGCCGCCGACGTCGGCGACCGGGACGCCGTCGCGGCCCTCGTCGCCTCGGTGCCGGCCGCGCACCCGCTGACCGCCGTCGTGCACACGGCAGGCGTCCTGGACGACGCGACCCTCCAGTCGCTGACCGAGGCACAGCTGGACGCCGTCCTGCGGCCGAAGGCGGACGCCGCCCGCCACCTCCACGAGCTGACCCGGGACCTGGACCTGACGGCCTTCGTGCTGTTCTCGTCGGTGTCCGGCCTCACCGGCACCGCGGGCCAGGCCAACTACGCGGCGGCCAACACCTACCTGGACGCGCTCGCCCAGCACCGCGCCGCGCACGGCCTGCCCGCCACCTCGCTGGCCTGGGGCCTGTGGGACGCCACGCACGGCATGGGGGCGTCCCTCACCGACGCCGACCTGGCACGCTGGGCGCGCGCCGGCATGACCCCGCTCACCCCGGAAGCGGGCCTCGCGCTCTTCGACCTGGCGCTGGCCGGCGACGAGCCGCTGCTGGCGCCCGTGGCCCTGGACCCGGGCAGGCTCGCGGCCGACGAGGCGGTACCGGTCCCGGCGCTGTACCGCGGGCTGGTGCGCCCGCGGCCGCGGCGCGCCGCCCGAAACGGCTCGCCCGGCGGCTCCGGCTCCGGCTCCGGCTCCGGCTCCGGCTCCGAGTGGGCACGGCAGATCGCCGGCCTGCCGGAGAACAAGCGGGGCGACGCCGTGCTGACCCTGGTGCGGACCGTCGTGGCCGCGGTGCTCGGCCACCCGGGCGCCACGGCCGTGGACCCGGCGCGCGCGTTCAACGACCTCGGTTTCGACTCGATGGCCGGCGTCGACCTGCGCAACCGGCTGACCGCCGCCACCGGCCTGCGGCTGCCCACCACGGCGGTCTTCGACCACCCGACCCCGAACGCGCTCGCCGCCTACCTGCTGACCGAGGCGGTGGCCACCCAGGCTTCCCAGGACCAGGACCAGGACCGGACCCGGGACCGGCGCGAGCGCGCCGGGGCCCGCACCGACGACCCGATCGCGATCGTCGGCATGGCGTGCCGCTACCCCGGCGGTGTGTCCTCCCCCGAGGACCTGTGGGACCTGGTCGCCAACGGGGTCGACGCCGTCAGCGAGTTCCCCTCCAACCGCGGCTGGGACGTCGAGAAGCTGTACGACCCGGACCCCGACCGGCCGGGCACCTCCTACGTCCGCGAGGGCGGCTTCCTGCACGACGCGGACCTCTTCGACCGCGAGTTCTTCGGCATGTCACCGCGCGAGGCGACCGCGACCGACCCGCAGCAGCGCCTGCTGCTGGAGACCGCCTGGGAGACCTTCGAGAACGCGGGCATCGATCCGGCCACCCTGCGCGGCAGCGAGACCGGCGTGTTCACCGGCGCCATGTACGACGACTACGCCTCGCGTCTGGAGGGCACCCCGGAGGAGTTCGAGGGCTTCCTGCTCGCGGGCAACCTCTCCAGCGTCCTCTCCGGCCGCCTGTCGTACACGTACGGTCTGGAGGGCCCGGCCGTCACGGTCGACACCGCCTGCTCCTCCTCGCTCGTCGCCATGCACATGGCCGTCAACGCGCTGCGCAACGGCGAGTGCGACCTCGCCCTCGCGGGCGGCGTCACGGTCATGAACAGCCCCAACACGTTCGTGGAGTTCTCCCGTCAGCGCGGCCTGTCCGCCGACGGCCGCTGCAAGTCCTTCTCCGACGACGCCGACGGCACCGGCTGGTCCGAGGGCGTCGGCCTGCTCCTCGTGGAACGCCTCTCCGACGCCCGCAAGAACGGCCACCGCGTCCTGGCGGTCATCCGCGGCACGGCCGTCAACCAGGACGGAGCCAGCAACGGCCTCACCGCACCCAACGGCCCCTCCCAGGAACGCGTCATCAAGCAGGCCCTCGCCAACGCCGGTCTGAACACCGACGACGTGGACGCGGTGGAGGCGCACGGCACCGGCACCCGCCTCGGCGACCCCATCGAGGCCCAGGCCCTCCTCGCCACCTACGGCCGCAACCGCACCACCGACAAGCCGTTGTACCTCGGCTCCCTCAAGTCGAACATCGGCCACTCCCAGGCAGCCGCCGGAGTCGGCGGCGTCATCAAGATGATCGAAGCCATGCGCCATGAGGTGCTGCCGCCGACCCTGCACGCCGACAAGCCGTCCAGCCACGTGGACTGGGACGCCGGCGCGGTCGAGCTGCTGACCGAGGCACGCGAGTGGCCCGCCACCGACGGCCGCCCGCGCCGCGCCGGCATCTCCTCCTTCGGCATCAGCGGCACCAACGCCCACGTCCTCATCGAGGAACCCCCGGCCGAGCCGCGCCCGGCCAGAAGGCCCGGTGCGTCGGGCGCCTCCGGTGCGGCGGGCGCGTCCGGTGCGCCCTCCCGTGTCCTGCCGTGGATCATCACCGGCAGGACCGAGAAGTCGCTGCGCGACCAGGCCGAGCGCCTGCGCCGGTTCGTCAAGGCGAGGCCCGGGCTGGAGGCGGCCGACGTCGCCTACTCGCTGGCCACCGGACGCGCCCTGCTCGACCAGGGCGTCGCCGTCCTGGGCGACAGCCGCGAAGCGCTCCTCGAGGGCCTGGCCGCGTTCGCCGGTTCGACCGACGGCCGGCAGGTTCCCGGCGTGGTCGGCACCCGTACCGCCCGCCCCGGCAGGACCGCCTTCCTGTTCACCGGTCAGGGCGCCCAACGGCTCGGCATGGGGCGCGAGTTGTACGAGACCAACCCGGTGTTCGCCGAGGCGCTGGACCGGGTGTGCGCCCATCTCGACCCGGAGCTGGTCCGTCCCGTGAAGGGGGTGCTCTTCGCCCCGGAGACGTCCGCCGACGCCGCGCTGATCGACCAGACGGCCTTCACCCAGGCCGCGCTGTTCGCCGTCGAAGTCGCTCTGTACCGCCTCTTCGAGCACTACGGCGTGCGACCGGACTACCTGCTCGGCCACTCCCTCGGCGAGGTCACCGCGGCCCATCTGGCCGGCGTTCTCGACCTCACCGACGCCTGTGTCCTGGTCGCCGAGCGCGGACGGCTGATGCAGGCCGCCCGCGAGGGCGGCGCGATGGCCTCGATCCAGGCCGCGGAGGACGAGGTCCGCGCCTCCCTGCTGCCGTACGGCGAGGAGCGGGTCTCCGTCGCCGCCGTCAACGGCCCCCGCGCCACCGTCGTCTCCGGCGACGAGGACGCCGTCACCGCGATCATGGAGGAATGGCGGGCCAAGGGCGCCCGGGTCAGGCTCCTGGCCGTCTCGCACGCCTTCCACTCCCCGCACATGGAGGAGATCCTCGACGAGTTCCGCGACATCATCTCGGACCTGACCTTCAGGGCCCCCGAGATCCCCGTCGTCTCCAACGTGACCGGTGTCCTCGCCACCGACGAGGAACTGATGTCACCGGACTACTGGGTCCGCCACATCCGGGGCACCGTCCGGTTCCACGACGGTGTGCGGTTCCTGCAGTCCGAGGGCGTCACCGAATACCTGGAGCTGGGCCCCGACGGCGTCCTGACCGCGCTCGCCGCGGCGTGCCTGACCGAGGAGGAGACCGGGGTGCTCGCCCCGGCGCTGCGCCGCGGGCGCCCCGAGGCGGAGTCCGTGGCGGCGGCACTGGCCCTGCTGCGGCTGCGCGGGGCCGGCCCCGACTGGACCAGGGTCCTCCCCGGCGCCCGCAGGGTCGACCTGCCCACGTACGCCTTCCAGCGCGAGCGGTACTGGCTGGACGGCCCGAACGCCCCGCTGGACGCCGCCGGCCTGGGCCTGACGTCCGCCCGGCACCCGCTGCTCGGCGCGGCCATGAGCCTGGCCGACCGGGACACCCACGTCTTCACCGGACGGGTTTCGTCGCACACCCACGGCTGGCTGGCCGAACACGCCGTCGACGGCAGGATCCTGCTGCCGGCCACCGCCCTGGTGGAACTGGCGATGCGCGCCGGTGAACAGACCGGCACCGAGGCACTCGACGAACTGCTGCTGTCGGCGCCGTTGGTGCTGCCGGCGCGGGGTGGTGTGCAGGTGCAGGTCGTCGTCGGGGAGGCCGATGACGCCGGACGTCGTGGGGTGGAGGTGTACGGGCGGCCCGAGCCGGACGACGACGTCGACGAGGCGGGTGAGGGACCGTGGACGCTGCACGCCCGGGGCCGGCTGGTTCCGGCGGAGGCGTCGGCGGGTGAGGCGCTGACGGTGTGGCCTCCGGCGGGCGCGCGGGAGGTGTCGCTGGAGGGCGCGTACGAGCGTCTGGAGGAACTCGGCTACACGTACGGTCCCGCCTTCCGGGGACTGCGGCGGGCCTGGCGCGGCGACGGGGAGGTCTTCGCCGAGGTGGTCCTGCCGGAGGGGCAGCGCGCCGAGGCCGGGCGCTACCTGCTGCATCCGGCCCTGCTGGACGCCGCCCTCCACACCCTCCTCCCCGGCGTCGTCGACGAGGCGGGCCGGGCCCGGCTCCCCTTCGCGTGGTCGGGTGTCACCCTCCACGCGGTGGGCGCCACCGCGCTGCGCGTCCGCCTGTCCGTGTCCGACCAGGACTCCGAGACCCTGGAGGCATCGCTCACGGTGGCGGACGGTACGGGTGCTCCGGTGGCGTCCGTGGAGGGGCTGACGCTGCGGCCGCTGTCGTCGGAGGCGCTGCGTGCGGCGGCGGCCCCGAGCGGCCCGGACGGCCTGTTCGCCGTGCGGTGGAAGCCCGTACCGGGTGGCACCGCACCGGCCCCGGACGGGGCCGAGGTGAGGGAGGTCGTCTCCGGCGGACGGTCCGCGCCCGAGGTCCTGCACGACACCCTGCACGGAATCCAGGAGTTCCTGACCGACGACAGCAAAGCGGACCACACCCTGATCGTGGTGACCCGCGGCGCCGTCGCCCTGGAGGGCGAGGAGATCGCCGACCTCGCGGCAGCCGGTGTCACCGGACTGGTACGGGTGGCACAGACGGAACACCCCGGCCGCATCGTCCTGGCCGACCTGGAACCGGACACCGACCTGGATGCCTCACTGATCCTCGCCACCGGCGAACCCCAGCTGGCCGTACGTGACGGAGTGACGTACGTGCCCCGACTGAACCGCGCCACGGGCGAACCCGGTGAGCGCACGGTGCGCTGGGACGAGGGCACCGTCCTCGTCACGGGCGCCACCGGAACCCTGGGCGCCGTGCTGGCCCGTCACCTGGTGACCGCGCACGGCGCACGCAACCTGCTCCTGGTCTCCCGCCGCGGACCCGACGCACCCGGCGCCACCGAACTCAAGGACGAACTGCGCACGCTGGGAGCCGAGGCCACCCTCGCCGCCTGCGACGTCTCCGACAGGGAAGCGGTCGCCGACCTGCTGGCGTCCGTCCCGGCCGACCGGCCCCTGAGGGCCGTGATCCACACGGCAGGAGTCCTCGACGACACCGTGCTCACCGACCTGACCCCCGAACGCCTGGACGCCGTGCTCAAGCCGAAGACCGAAGCGGCGTGGAACCTGCACGAGGCCACCCTCGGCGACGAAATCGACGCGTTCGTCGTCTACTCGTCGATCGCGGGTCTGATCGGCAATGCCGGCCAGGCCAACTACGCCGCCGCCAACACCTACCTCGACGCCCTCGCCCAGCACCGCGCGGCCCTCGGACTGCCCGGCGTGTCACTCGCCTGGGGCCTGTGGAACCAGACCAGCACCATCAGCGGCGAACTGAACGAGACGGACCTGCGCCGCCTGGCCCGTATCGGCCTCAAGCCCCTGGCCACGGACGAGGCGATGGAGCTGTTCGACTCCGCCCTGGCGGGAACCGAGCCGGTCCTCGCCGTCAGCCGCATCGACACCGCGGCCCTGCGCAAGGCGGGTGACGGCCTGCCACCGCTGCTGCGCGACCTGGCCCCGGCCGGACGCCGCCGCACGGCCGCCTCGGCCGGCCGGTCCGGCGGCCAGGACGCGGGCCCCTCACTGGCCGAGCGCCTGGGCGCCCTGTCCCGGGAAGAGCGCGAACAGGCCCTCGTCGACCTCGTGCGCGCCCAGGTCGCCGCGGTCCTCGGACACACCGACGCCGGTGCCGTCGACCCCCAGCGCGCCTTCCAGGAACTCGGCTTCGACTCACTGACCGCCGTCGAACTGCGCAACCAGCTCAACGGCGCGACCGGACTGCGCCTGCCGAGCACACTCGTCTTCGACCACCCCAACCCCGCCGCCCTCGCCGCGCACCTGCATCGGCAGATCAAGGTGGAGGCGGCGTCGCCCGCGGACTCGCTGGTCGAGGAGCTCGGCCGGCTCACGGCCGCCGTCCGGTCGGCGGCCGCCGATCCCGCGGCCTACGAGAGCGTCGCCGGGCAGCTGCGCGAGCTGCTGGGCGTCGCCGAGCAGGCGAGCGGCCGTACGTCCGCCGACGAGGTACTGGCGGCCGGTGACCTGGACGAGGCGAGCGACGAGGAGCTGTTCGCGCTCCTCGACGACCTGAACTGA	MTTSEHDTHAEPTWEGGATGDRAEPIAVIGMSCRLPGADSPAAFWDLLTRGADAITPVPEGRWGPDGRSLGAGRGGFLDAVDAFDAPFFGISPREAAAMDPQQRLVLELAWETLEDAGVVPASLRGSRTAVFVGALRDDYTSLLYLHGAEAVTQHTMTGVNRGVIANRVSYHLGLHGPSMTVDSAQSSSLVAVHLACESLRAGEADGALVAGVNLNLLAENVVTESRFGALSPDGTTYTFDARANGFVPGEGGGMVLLKPLSRARADGDRIYGVVRSSAVNSDGATDGLTVPSAAAQEAVLREAYERAGIAPDEVQYVELHGTGTPVGDPLEAAALGAALGRGRTARTALRVGSVKTNIGHLEGAAGIAGLIKTLLSLHHRRLPASLNFETPNPRIAPDELGIAVQREPSAWPDEDRALIAGVSSFGMGGTNAHVVVSEAPADPAVISEAPAGPAAVAGPGAPAAGVPLPWIVTGHDEDALRAQAAKLRAFAAERPGQPAEDTGRALATTRTFLGHRAVVVADGRDALLAGLDALATATPAASVVSGVARPGGLAFLFTGQGAQRTGMGQELYAAFPAYATAFDEVAAHLDPLLPRPLAELVADDTALHETGATQPALFAVEVALFRLVESWGLRPDRLAGHSIGELAAAHVAGVFSLADAARLVAARALLMQALPTGGAMIAVEATEAEVLPLLADHEGALAVAAVNGPRSVVLSGDADAAAEVAAALRDRGRRTKRLTVSHAFHSPHMDPMLAEFRAVAASLDYAEPVIPVVSTVTGEPVTAGQFTSPDYWVEQVRRPVRFLDTVRALESAGARTFLELGPEGVLSSLVGECAADADAVAAVPLLRAGRSEPLTALSALATAFTRGAEPGWTALYGGRPARHVELPTYAFQRRPHWPAGLRTAVDPSRPAPAPEAAVPAAPPAATPRGELGRRLAALDGAERRRAVEDLLHPHIAAVLEYEPGRRIPDHTPFRDLGFSSLMATELRGTLARATGLKLPGGLLFDHPTPRALAEFVEAELLGEAAVADETADGSAAGADGEAIAVVAMACRYPGGVASPEDLWRLVTEGGDAVGEFPTDRGWPEDLYDPDPDRPGRSSVRHGGFLHDAGDFDAAFFGISPREALAMDPQQRLLLETAWESVERAGIDPARLRGTRTGVFVGATGLEYGPRMDEAPESVQGGVLTGTTTSVMSGRIAYQLGLVGPAITVDTACSSSLVALHLAIRSLRSGETDLALAGGATVMSSPGMFVEFSRQRGLAPDGRCKAFADDADGTGWSEGVGLLLLERLSDAQKNGHTVLAVLRGSAVNQDGASNGLTAPNGPSQQRVIQQALADSGLSPADVDAVEAHGTGTRLGDPIEAEALKAVYGPGHDSDRPLHLGSLKSNLGHTQAAAGVGGVIKMVQAMRHGVLPRTLHVDRPTSRVDWSDGTVALLTEERPWPGTDRPRRAAVSSFGISGTNAHLVVEEAPAGAPAGTDGESARPGGTAALAVGPAPYVLTARDPDALREQAARLAAHVTASGTGTRLADLGFSLATTRTAFEHRAVVLASDTGDLLAGLTGLAAGTGAPNTVTGTADTPGRTAFLFTGQGAQRAGSGRELYAAQPVFAAALDEVCAAFDGLLEVPLRDVLFGEGAGEGLIDRTAYTQPSLFAVEVALFRLLTHHGLTPDLLAGHSIGELAAAHAAGVLSLEDAAVLVAARGRLMQSAPAGGAMTAVEGTEEEIAAGLAGQESAVSVAAVNSPSSVVISGDAEAVEEAARGWREAGRRTHRLTVSHAFHSPHMDGVLEEFRAVAAGLTFHRPRIPIVSTVTGEIATAEQLTSPDYWARQIRETVRFAAATRRLAAEGATVLVEVGPDAVLTALARRILEDTPAAAVTAVPVLRAGRPEAETFATAAAAAYAQGAPLDVASFFPGAARTDLPVYPFRRTRFWLNAAPRTDARSLGLDPAEHPLLTTAVEFAEREDALFTSRLSRAAQPWLGDHAIAGTVIAPGTAFLELAVAAGGHVGAPHLTEMTLEAPLPLPERGAVRVQVAVGAPDRDGQRPFTVHARPDTADGALPWTRHATGLLARAGAAPAADADLTSWPPAGATAENLDDVYDRLAALGYAYGPAFRALRAVWRRGTDLFAEVGLPEAQTGGAAAYGLHPALLDAVLHPLVLDAAAETDPAHIRLPFAWNDVTLHAAGAAELRARISPAGPGHAAITVADGTGAPVADLDLALRAVPRDRLTAASHTGAGSLFTVEWNELPPPAPDTSLVWSEAVASDDSLDSAEPADVVVLRVPAVPDGADDPRPTTGRVLRLVQRWLADERFAGSRLALVTRRAVAARPGDDVDLAGAPVWGLIRSAQSEHPDRIVLIDLDDDPAADSLLPAALAAEEPQLAVRDGRLHAPRLARTPRAAGAPTPRFTPDGTVLVTGGTGGLGALFARHLVTGHGVRHLLLSSRRGPDAPGAAELAGELTALGAEVTVTAADVGDRDAVAALVASVPAAHPLTAVVHTAGVLDDATLQSLTEAQLDAVLRPKADAARHLHELTRDLDLTAFVLFSSVSGLTGTAGQANYAAANTYLDALAQHRAAHGLPATSLAWGLWDATHGMGASLTDADLARWARAGMTPLTPEAGLALFDLALAGDEPLLAPVALDPGRLAADEAVPVPALYRGLVRPRPRRAARNGSPGGSGSGSGSGSGSEWARQIAGLPENKRGDAVLTLVRTVVAAVLGHPGATAVDPARAFNDLGFDSMAGVDLRNRLTAATGLRLPTTAVFDHPTPNALAAYLLTEAVATQASQDQDQDRTRDRRERAGARTDDPIAIVGMACRYPGGVSSPEDLWDLVANGVDAVSEFPSNRGWDVEKLYDPDPDRPGTSYVREGGFLHDADLFDREFFGMSPREATATDPQQRLLLETAWETFENAGIDPATLRGSETGVFTGAMYDDYASRLEGTPEEFEGFLLAGNLSSVLSGRLSYTYGLEGPAVTVDTACSSSLVAMHMAVNALRNGECDLALAGGVTVMNSPNTFVEFSRQRGLSADGRCKSFSDDADGTGWSEGVGLLLVERLSDARKNGHRVLAVIRGTAVNQDGASNGLTAPNGPSQERVIKQALANAGLNTDDVDAVEAHGTGTRLGDPIEAQALLATYGRNRTTDKPLYLGSLKSNIGHSQAAAGVGGVIKMIEAMRHEVLPPTLHADKPSSHVDWDAGAVELLTEAREWPATDGRPRRAGISSFGISGTNAHVLIEEPPAEPRPARRPGASGASGAAGASGAPSRVLPWIITGRTEKSLRDQAERLRRFVKARPGLEAADVAYSLATGRALLDQGVAVLGDSREALLEGLAAFAGSTDGRQVPGVVGTRTARPGRTAFLFTGQGAQRLGMGRELYETNPVFAEALDRVCAHLDPELVRPVKGVLFAPETSADAALIDQTAFTQAALFAVEVALYRLFEHYGVRPDYLLGHSLGEVTAAHLAGVLDLTDACVLVAERGRLMQAAREGGAMASIQAAEDEVRASLLPYGEERVSVAAVNGPRATVVSGDEDAVTAIMEEWRAKGARVRLLAVSHAFHSPHMEEILDEFRDIISDLTFRAPEIPVVSNVTGVLATDEELMSPDYWVRHIRGTVRFHDGVRFLQSEGVTEYLELGPDGVLTALAAACLTEEETGVLAPALRRGRPEAESVAAALALLRLRGAGPDWTRVLPGARRVDLPTYAFQRERYWLDGPNAPLDAAGLGLTSARHPLLGAAMSLADRDTHVFTGRVSSHTHGWLAEHAVDGRILLPATALVELAMRAGEQTGTEALDELLLSAPLVLPARGGVQVQVVVGEADDAGRRGVEVYGRPEPDDDVDEAGEGPWTLHARGRLVPAEASAGEALTVWPPAGAREVSLEGAYERLEELGYTYGPAFRGLRRAWRGDGEVFAEVVLPEGQRAEAGRYLLHPALLDAALHTLLPGVVDEAGRARLPFAWSGVTLHAVGATALRVRLSVSDQDSETLEASLTVADGTGAPVASVEGLTLRPLSSEALRAAAAPSGPDGLFAVRWKPVPGGTAPAPDGAEVREVVSGGRSAPEVLHDTLHGIQEFLTDDSKADHTLIVVTRGAVALEGEEIADLAAAGVTGLVRVAQTEHPGRIVLADLEPDTDLDASLILATGEPQLAVRDGVTYVPRLNRATGEPGERTVRWDEGTVLVTGATGTLGAVLARHLVTAHGARNLLLVSRRGPDAPGATELKDELRTLGAEATLAACDVSDREAVADLLASVPADRPLRAVIHTAGVLDDTVLTDLTPERLDAVLKPKTEAAWNLHEATLGDEIDAFVVYSSIAGLIGNAGQANYAAANTYLDALAQHRAALGLPGVSLAWGLWNQTSTISGELNETDLRRLARIGLKPLATDEAMELFDSALAGTEPVLAVSRIDTAALRKAGDGLPPLLRDLAPAGRRRTAASAGRSGGQDAGPSLAERLGALSREEREQALVDLVRAQVAAVLGHTDAGAVDPQRAFQELGFDSLTAVELRNQLNGATGLRLPSTLVFDHPNPAALAAHLHRQIKVEAASPADSLVEELGRLTAAVRSAAADPAAYESVAGQLRELLGVAEQASGRTSADEVLAAGDLDEASDEELFALLDDLN	MTKKALFFAISTMFLSACSFNTVQQHQIQSISTNKNSEKIKSLFDQAQTEGVLVIKRGQIEEVYGNDPKRASTDYVPASTFKMLNALIGLEHHKATPTEVFKWDGQKRLFPDWEKDMTLGDAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNADIGSKVDDFWLVGPLKITPQQEAQFAYELAHKTLPFSKNVQEQVQSMLFIEEKNGRKIYAKSGWGWDVEPQVGWLTGWVVQPQGEIVAFSLNLEMKKGIPSSIRKEIAYKGLEQLGIL	1683.15	gnl|BL_ORD_ID|3791|hsp_num:0	4861			177	342	cloxacillin; oxacillin; cefalotin
BGC0001433.1|Argimycin_13 # 30149 # 40786 # 1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.735	BGC0001433.1|Argimycin_13 	30149	40786	+	Loose	500	32.7278	OXA-526	33.33	3005756	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGGCGAACGAGCAGGAACTCCGCGAGTACCTCAAGAAGGCCATCGCCGACGCGCGCGACGCGCGCAGGCAGCTGCGCGAGGTCGAGGACAAGGCGCAGGAGCCGATCGCGATCGTCGGCATGGCGTGCCGCTATCCCGGCGGTGTGTCCTCCCCGGAGGACCTGTGGGACCTGGTCGCCAACGGCGTGGACGCCGTCAGCGAGTTCCCCTCCAACCGCGGCTGGGACGTCGAGAAGCTGTACGACCCGGACCCCGAGCGGCCGGGCACCTCCTACGTCCGCGAGGGCGGCTTCCTGCACGACGCGGACCTCTTCGACCGCGAGTTCTTCGGCATGTCACCGCGCGAGGCGCTCGCCATCGACCCGCAGCAGCGCCTGCTGCTGGAGACCGCCTGGGAGACCTTCGAGAACGCGGGCATCGTCCCGGCAGCCCTGCGCGGCAGCCGCACCGGTGTCTTCACCGGCGCGATGTACAACGACTACGGCTCCCGCCCCGACCTGCCCGCCGAGGGCAACGAGGGCTACCTCTTCAGCGGCAGCGCGGGTTCCATCGCGTCGGGCCGGATGGCGTACACCTTCGGTCTGGAGGGCCCGGCCGTCACGGTCGACACCGCCTGCTCCTCCTCGCTCGTCGCCATGCACTTGGCCGTCAACGCGCTGCGGAACGGCGAGTGCGACCTCGCGCTCGCCGGCGGCGTCGCCGTCATGTCGACGCCCACGGCGTTCGTGGAGTTCTCCCGGCTGCGTGGTCTGTCCACCGACGGCCGCTGCCGGTCCTTCTCCGAGGACGCGGACGGCACCGGCTGGTCCGAGGGCGTCGGCCTGCTGCTGGTGGAGCGGTTGTCCGACGCCCGCAAGAACGGCCACCGGGTCCTGGCGGTGATCCGGGGCAGCGCGGTCAACCAGGACGGGGCCAGCAACGGGCTGACCGCGCCCAACGGCCCCTCCCAGGAGCGCGTGATCCTCGCCGCCCTGGCGAACGCCGGTCTGACCACGGCCGACGTGGACGCCGTCGAAGCGCACGGCACGGGTACCCGCCTGGGTGATCCCATCGAGGCGCAGGCGCTGCTCGCCACCTACGGTCAGGGCCGGCCGGCCGGACACCCGCTGTACCTGGGCTCGCTCAAGTCGAACATCGGCCACGCGCAGTCGGCCGCCGGTGTCGGCGGTGTCATCAAGATGATCGAGGCGATGCGGCACGGGGTGCTGCCGAGGACGCTCCACGTGGGGGAACCCTCCAGCCACGTGGACTGGGACGCCGGTGCGGTGGAGCTGCTGACCGAGGCGCGCGAGTGGCCCGAGGTCGACGGCCGGCCGCGCCGCGCGGGTGTCTCGTCCTTCGGCTTCGGCGGAACGAACGCCCACGTCGTCATCGAGGAGCCCCCGGCCGCGCCCGAGGAGCAGGACACCACCGAACGCACCGAACTGCCGTTGATTCCGTGGGTGTTGTCGGGCAGGAGCGCGCAGGCGGTCCGTGACCAGGCAGCCCGCCTGCTGACCCACCTCGACACCCACCCCGCCCTCACCGCGCAGGACATCGCCCTGTCGCTGGCGACCGAGCGGACGGCGTTCGACCACCGCGCGGTGGTCACGGGCACCGACCGCACCGAACTCCTCGACGCCGTCAGGGCGTTGGCGGAGGGCGGCGGTACGGAACCGTCACGAGTGCACGGTTCGGGCTCCACCGCCTTCCTGTTCACGGGGCAGGGAGCACAACGGCTCGGAATGGGACGGCAACTGCACGCGGCGTTCCCGGCGTTCGCCACCGCCTTCGACGAGGTCGCCGCCGCCCTCGACCCCCACCTGCCCCGCCCGATCAACGACGTCATCACCGACGGCGACGACCTGGACCGCACCGAATTCACCCAACCCGCCCTCTTCGCCATCGAAGTCGCCCTCTACCGCCTCATCCACTCCTGGGGCATCACCCCCGACTACGTCGCAGGCCACTCCATCGGCGAACTCGCCGCCGCCCACGTGGCGGGCGTGTTCTCCCTCGAAGACGCGGCGCGGCTGGTGGCCGCCCGCGGACGCCTCATGCAGGCCGCCCGCGAGGGCGGCGCCATGGCCGCCGTCCAGGCCTCGCAGGACGAGGTCGCGGCGGCGCTCGCGGAGGAATCGGGTGTGGTCGCGGTGGCGGCGGTGAACTCGCCGCTGTCGACGGTGATCTCCGGTGACGCGGAGGCGGTGGAGCGGCAGGTGGCGCGGTGGCGCGAGCACGGCCGCAAGGCCGTACGGCTGGCCGTCTCGCACGCCTTCCACTCCCCCCACATGGACGACATCCTCGACGCCTTCCGGGAAGTCGCCGCCACCGTCACCTACCACAAACCCCGCATCCCCCTCGTCTCCACCCTCACCGGACGCCTCACCGACGCCGACGAACTCACCACCCCCCAGTACTGGACCGACCAGATCCGCGGCACCGTCCGCTTCACCGACGCCCTCACCAGCCTGCGCGAAGCCGGGGCGGGCGTCTTCGTCGAGATCGGCCCCGACGCCGTCCTCACCGCCCTCACCCGCGACACGGTCGAGGACGCCACCGCCCTCCCCCTCCTCCGCCGCGACCACGACGAGACCCACACCCTGATATCCGGCGTCGCCCGGGCATTCACCGCGGGCGCGCCGGTCGACTGGTCCGCCTTCCTCGGCCCCGCAACCACAACCCCCGCCCCCCTGCCCACCTACGCCTTCCAACGCGAACGCCACTGGCTCGACCCCGTCGACGCCCCTGCCGACGCCGAGGGCCTGGGTCTGAAGGCGGTCGGACACCCCATCCTGGGCGCTTCGCTGGGTCTGGCCGCCCGGGACGAGTACGTGCTGACCAGCCGCGTCTCGCTGCGCACCCACCCCTGGCTGGCCGACCACGTGGTCCTCGGCGCCACGTTGCTGCCCGGCACCGCGTTCGTCGAACTCTGTGCCCGCGCGGGCGACCAGGTCGGCGCTCCCCGCGTGGAGGACCTGACCCTGTCGGCGCCGTTGGTGCTGCCGGCGCGGGGTGGTGTGCAGGTGCAGGTCGTCGTCGGTGAGGCCGATGACGCCGGACGTCGTGGGGTGGAGGTGTACGGCCGGCCCGAGCCGGACAGCGACGTCGACGAGGCGGGTGAGGGACCGTGGACGCTGCACGCCCGGGGCCGCCTGGTGCCGGCCGAGGCGTCGGCGGGTGAGGCGCTGACGGTGTGGCCTCCGGCGGGCGCGCGGGAGGTGTCGCTGGAGGGCGCGTACGAGCGTCTGGAAGAACTCGGCTACACGTACGGTCCGGCGTTCCAGGGGTTGCGACGGGCCTGGCGCGGCGACGGGGAGGTCTTCGCCGAGGTGGTCCTGCCGGAAGGGCCCCATGCCGAGGCGGGACAGTATCTGCTGCATCCGGCCCTGCTGGACGCCGCCCTCCACACCCTCCTCCCCGGCGTGGTCGACCCGGACCGAGAGGCCCTCGTGCCCTTCGGATGGGAGGGCGTCACGATCCACGCGGTGGGCGCCGGGACGGTCCGGGTGCGCTTCTCCCTCGGCGCCGTCGACTCCGTCGCACTGACGGTGGCGGACGGTACGGGTGCTCCGGTGGCGTCCGTGGAGGGGCTGACGCTGCGGCCGCTGTCGTCGGAGGCGCTGCGTGCGGCGGCGGCCCCGAACGGCCCGGACGGCCTGTTCGCCGTGCGGTGGAAGCCCGTACCGGGTGGTACCGCACCGGCCCCGGACGGGGCCGAGGTCGTGGAGGTCGTCTCCGGCGGACGGTCCGCGCCCGAGGTCCTGCACGACACCCTGCACGGGATCCAGGAGTTCCTGACCGACGACAGCAAAGCGGACCACACCCTGGTCGTGGTGACCCGCGGCGCCGTCGCCCTGGAGGGCGAGGAGATCGCCGACCTCGCCGCGGCCGGTGTCACGGGGCTCGTGCGGGTGGCACAGACGGAACACCCCGGCCGCATCGTCCTCGCCGACCTGGAACCGGACACCGACCTGGATGCCTCGCTGATCCTCGCCACCGGCGAACCCCAGCTGGCCGTACGTGACGGAGTGACGTACGTGCCCCGCCTGAACCGCGCCACGGGCGAACCCGGTGAACGCACGGTGCGCTGGGACGAGGGCACCGTCCTCGTCACGGGCGCCACCGGAACCCTGGGCGCCGTGCTGGCCCGCCACCTGGTGACCGCGCACGGAGCACGCAACCTGCTCCTGGTCTCCCGCCGCGGACCCGACGCACCCGGCGCCACCGAACTCAAGGACGAACTGCGCACGCTGGGAGCCGAGGCCACCCTCGCCGCCTGCGACGTCTCCGACAAGGACTCCCTGGCGGACGTCCTGGCACGGATTCCGGCCGACCGGCCCCTGAAGGCCGTGGTCCACACGGCAGGAGTTCTCGACGACACCGTGCTCACCGACCTGACCCCCGAACGCCTGGACGCCGTAATGGCGGCGAAGGCGGACGCGGCGTGGCACCTGCACGAGCTGACGCAGGACCTGGAGCTGTCCGCCTTCGTTCTCTACTCGTCGATCGCGGGTCTGATCGGCAATGCCGGCCAGGCCAACTACGCGGCGGCCAACACCTACCTCGACGCCCTCGCCCAGCACCGCGCGGCCCTCGGACTGCCCGGCGTGTCACTCGCCTGGGGCCTGTGGAACCAGACCAGCACCATCAGCGGCGAACTCGGTGACGCGGACCTGCAGCGCATCAAGCGCCTGGGGCTGCTGCCCCTTGCCACGGACGAGGCGATGGAGCTGTTCGACTCCGCCGTGGCGGGAACCGAGCCGGTCCTGGCCGTCAGCCGCATCGACACCGCGGCCCTGCGCGCACAGCGCCAGGCTCCCACCCCGCTCCTTCGCGCCCTGGTCCCGGCCGGTCCGCGACGCGCGAACGACACGCGGAGTGATGCCGCCGCCTCACTGGCCCAGCGCCTGGGCGCCCTGTCCCGGGAAGAGCGCGAACAGGCCCTCGTCGACCTCGTGCGCGCCCAGGTCGCCGCGGTCCTCGGACACACCGACGCCGGTGCCGTCGACCCCCAGCGCGCCTTCCAGGAACTCGGCTTCGACTCACTGACCGCCGTCGAACTGCGCAACCAGCTCAACGGCGCGACCGGACTGCGCCTGCCGAGCACACTCGTCTTCGACCACCCCAACCCCGCCGCCCTCGCCGCGCACCTGGCCTCCGAGCTGTTCGGCGAGGAGGAGTCCGTCGCCGTCACCGCGGACTCCGCCTCCATGGAACCGATCGCGATCGTCGGCATGGCGTGCCGTTACCCCGGCGGTGTGTCCTCCCCCGAGGACCTGTGGGACCTGGTCTCCGGCGAAGTCGACGCCATCAGCGAGTTCCCGTCCAACCGCGGCTGGGACGTCGAGAAGCTGTACGACCCGGACCCGGAGCAGTACGGCACGTCGTACGTCCGCGAGGGCGGCTTCCTGCACGACGCGGACCTGTTCGACCGCGAGTTCTTCGGCATGTCACCGCGCGAGGCGACCGCGACCGACCCGCAGCAGCGCCTGCTGCTGGAGACCGCCTGGGAGACGCTGGAGAACGCGGGCATCGTCCCGACCACCCTGCGCGGCAGCCGCACCGGCGTCTTCACCGGCGTGATGTACCACGACTACGCCACCGCCACCGGGACCGTCCCGGAGGAGCTGGAGGGCTACCTCGCCGCCGGCAGCGCGGGCAGTGTCGCCTCCGGCCGGCTGTCGTACACCTTCGGTCTCGAAGGCCCGGCGATCACGGTCGACACGGCGTGCTCCTCCTCGCTGGTGGCCCTGCACATGGCCGCGGGCGCGCTGCGCAACGGCGAGTGCGACCTCGCCCTCGCGGGCGGCGCCACGGTCATGGCGACACCCGCCACGTTCGTGGAGTTCTCCCGTCAGCGCGGCCTGTCCGCCGACGGCCGCTGCAAGTCCTTCTCCGAGGACGCGGACGGCACCGGCTGGTCCGAGGGCGTCGGCCTGCTGCTGGTGGAACGCCTCTCCGACGCCCGCAAGAACGGCCACCGGATCCTGGCGGTCATCCGCGGCACGGCCGTCAACCAGGACGGGGCCAGCAACGGCCTCACCGCCCCCAACGGCCCCTCCCAGGAACGCGTCATCAAGCAGGCCCTCGCCAACGCCGGCCTGAACACCGACGACGTGGACGCGGTGGAGGCGCACGGCACCGGCACCCGCCTCGGCGACCCCATCGAAGCCCAGGCCCTCCTCGCCACCTACGGCCGCAACCGCACCACCGACAAGCCGTTGTACCTCGGCTCCCTCAAGTCGAACATCGGCCACTCCCAGGCAGCCGCCGGAGTCGGCGGCGTCATCAAGATGATCGAGGCGATGCGGCACGGGACCCTCCCCCGCACCCTCCACGCCGACAAGCCGTCCAGCCACATCGACTGGGACGCCGGTGCGGTGGAGCTGCTGACCGAGGCACGCGAGTGGCCCGAGGTCGACGGCCGCCCGCGCCGCGCCGGCATCTCCTCCTTCGGCATCAGCGGCACCAACGCCCACGTCGTCATCGAGGAGCCCCCGGCCGCGCCCGAGGAGCAGGACACCACCGAACGCACCGAACTGCCGCTGATTCCGTGGGTGTTGTCGGGCAGGAGCGCGCAGGCGGTCCGTGACCAGGCAGCCCGCCTGCTGACCCACCTGGAGACCCACCCCGCCCTCACCGCACAGGACATCGCCCTGTCCCTGGCCACCGAACGCGCCGCCTTCGACCACCGCGCGGTGGTCACGGGCACCGACCGCACCGAACTCATCGACGCGGTAAGAGCGCTGGCAGAAGGCACCGGCACCCAGCCGGCCCAGACACATCGCCCGGGCTCCACAGCCTTCCTGTTCACGGGGCAGGGAGCGCAGCGGCTCGGAATGGGACGGCAACTACACGCGGCGTTCCCGGCGTTCGCCACCGCCTTCGACGAGGTCGCCGCCGCCCTCGACCCCCACCTGCCCCGTCCGATCAGCGACGTCATCACCGACGGCGACGGCCTGGACCGCACCGAGTTCACCCAACCCGCCCTCTTCGCCATCGAAGTCGCCCTCTTCCGCCTCGTCCACTCCTGGGGCATCACCCCCGACTACGTCGCAGGCCACTCCATCGGCGAACTCGCCGCCGCCCACATCGCCGGAGTCTTCTCCCTCGAAGACGCCGCACGACTGGTCGCCGCCCGCGGACGCCTCATGCAAGCCGCCCGCGAGGGCGGCGCCATGGCCGCCATCCAGGCCGCGGAGGACGAGGTCCGCGCCTCCCTGCTCCCCTACGGCGAGAAGCGGATCTCCGTCGCCGCCGTCAACGGCCCCCGCGCCACCGTCATCTCCGGCGACCAGGACACCGTCACCAAGGTCATGGAGGACTGGCAGGCCAACGGCACCCGCGTCAAACGCCTGACCGTCTCCCACGCCTTCCACTCCCCCCACATGGACGACATCCTCGACGAGTTCCAACAGGTCGCCGCCACCCTCACCTACCACAAACCCCGCATCCCCCTCGTCTCCACCCTCACCGGACGCCTCGCCGACGCCGACGAACTCACCACCCCCCAGTACTGGACCGACCAGATCCGCGGCACCGTCCGCTTCACCCACGCCCTCACCACCCTCCACGAAACCGGCGCCCGCGTCCTCATCGAGATCGGCCCCGACGCCGTCCTCACCGCCCTCACCCGCGACACCCTCGACAACACCACCGCCCTCCCCCTCCTCCGCCGCGACCACGACGAGACCCACACCCTGATCACCGGTGTCGCCCAGGCATTCACCGCGGGCGTCCCGGTCGACTGGTCCGCCTTCCTCGGCCCCGCAACCACAACCCCCGCCCCCCTGCCCACCTACGCCTTCCAACGCGAACGCCACTGGATGGAGCGCAAGGACGCCGTTCCGGCCGACGAGGCGCGCGGAGGGAGCTCGCTCGGTCATCCGCTGCTCGCCGCGAAGGTCGAACCGGCGGGGAGCGAAGGGGTGTTGTTCAGCGGCCGGGTCTCGGTCGAGACGCATCCGTGGCTGGAGACGTACACCGTCCTGGACGCCCCCGTCCTGCCCACCGCCGCGCTCGTGGACCTCGTCGTGCGCGCCGGTGACGAGGTGGGCCTCGGCACGCTCGACACCCTCACCGTGCACACGCCGCTCGTGCTCTCGGCGCTGACCCCGACGGAGATCCAGCTCGCCGTCGCCGGCCCCGACGAATCGGGTCTGCGGGCCTTCACCCTGTACGCCCGGCCGGCCGACGAGGGCGCTCGCTGGACCACGTACGCGGACGGCGGTCTGTCCGTCACCGCCGCCCAGCCGGTGCGTGCCGTCGGCGACGGCAGCGGTACGGAGGTGGCGCTCGCCGACGAGCTGCTGCCGGACGCCGTCCGCTACGGACTGCACCCGGGGCTGCTGGAGGCGGCTCTGCGTGCGGCGGAGGAGGCCGACGCCGTCGCCCCGGCCCGTCCGGGCACCGTTCTCGTCCCCGCCGAATGGCACGACGTGCGGCTGCACGCGAGCGGTGCCACGGTCGTCCGTGTCCAGTGGCAGGCCGTCGACAGGCGCACCCTGGCCGTCCGGCTCACCGACGCCGCAGGCGAGCCGGTCCTCACGGTCGGCCGGCTGGTCTTCCAGGAGGTGCCGTACGACCGGTTCGCCGCCGCCGGCCGGGCGGCCCTGCCGCTGTACCGCACCGAGTGGGGCATCGCCGAGCTGCCGACGGCCGAGGCCCCCCTGCGCTGGGCCGACCTGGGCCCGGACGGCGGCGACGGCACCGGCACCGCCTACTCGACCCTCTCCGAAGCGGCGGAGGCCATCGCGGCGGGTGCCCCCGTCGACGCCTTGCGCGTGTGGGCGCACGACGAGTCCGGCACCGACGTGGTCGACGCCCTGCACCGGCGCACCCGTGACGCCCTCGCCCTGGTCCAGGAATATCTGGCCGACGAGCGTCTCGGGGACGTCCCGCTGGCCGTGGTCACCCGCGGTGCCGTCGCCGTCGGCGCCGAGGAGGTCGCCGACCTGGCAGGTGCCGGAGTCCGGGGTCTCCTGCGCTCCGCGCAGGCCGAGGCACCGGGCCGGATCTTCCTCCTCGACCTGGAGCGGTCGGCGGGCGGCGAGGGCGAGCCGCTCGCACCGGACGCGCTGTTGTCGGCGGTCGTCGCCGCCGACGAGCCGGAGGCCGCCGTACGCGACGCCGGGATCCGCGTGCCGCGCCTGCGCCGCGTCGACTCCACCGCGGCCGCCCCGTCCGTGCCCCCGCGATCCGATGCCGACCTGCCCGTCCCCGCTCGATCCGATGCCGACCCGTCCGTCCCCGCTCGATCCGATGCCCGCCCCTCCCGTCCCGGCTTCGACCGGTCACCCGGGGGGACCGTGCTGATCACCGGCGGCACCGGAGCCCTCGGCGCTCTGGTGGCCCGCCGCCTGGTGGCCGAGCACGGCGTACGGCACCTGCTGCTGCTCGGCCGCGAGGGCGCGGCGGCCCCGGGCGCCGAGGCCCTGGCCGAGGAGCTGACCGGGGCGGGTGCCACGGTCACCGTCACGGCCTGCGACGCCGGGGACCGCGCCGCGCTCGCGGCCGTCCTGGACGGCATCCCCGCCGAGCACCCCCTCACCGCGGTCGTCCACGCCGCGGGCGTCCTCGACAACGCGCTGATCGCCGACCTGGGCGCACCGAGCCTGGCCGGGGTCCTCGCGGCCAAGGCCGACGCCGCCTGGCACCTGCACGAACTGACGCGGGACCGGGACCTGTCCGCCTTCGTCCTGTTCTCGTCGAGCGTGGGCGTCCTCGGCGGGCCGGGTCAGGCCAACTACGCCGCCGCCAACGCGTTCGTCGACGCCCTGGCCGGCCTGCGCGCCGCCCAGGGCCTCCCGGCCACCGCGATCGGCTGGGGCGTGTGGGACCCCGCCGAGATCGGCGGCGGCATCAACACCGCCCTCGGCGAGTCGGGCCACAAGCGCTACACCAGGGAGGGCTTCCGGCTCATCCCCGCGCAGGAGGGCCTCGGCCTGCTCGACGCCGCGCTCGCGGAGGGCGTGGCCCATCTGGTGGCCCTGCCGCTGGACCTCGCGGCCCTGCGGGCGCACGGCCGGGTACCGGCCGCGCTGCGCGACCTGGTCCCCGCGCCGGGCCGCCGGGGCGCCGCGCACGGCGTGGACGCCGCGGGCGGTGCCGACGGCCGGGTCTCGCTGGAGCAACGGCTGGCCGCCCTGCCCGCCGAGGAGCGCGAGCAGGCCGTGCTCGACCTGGTGCGCGGCGAGATCGCGGCGGCGCTCGGCCACGCCGGAGCCCATCAGGTCGCCGCCCACCGGGCCTTCCAGGACCTCGGTTTCGACTCGTTGACCGCCGTCGACCTGCGCAACCGGCTGACGACCGCCACCGGTCTGCGGCTGCCCTCCACGCTGGTCTTCGACCACCCGAACCCCGAGGCGCTCGCCGCCCACCTGCTGGGCCGGCTGGACGTGGGCGACACACCGGGCGGGACCCCCGCCATGGCGGAGCTCGACCGCCTGGAGGCGGCACTGCTCGGTACGGACGCCCCCGACGACGAGGAGACCCGCTCCGCGGTCACCGTCCGGCTGAAGGCGCTGCTGGCGCGGATGACGGCGGCGGAGACACCCGAGGACGACGCGGCGGACGTGACCGAGTCCATCGAGGCCGCCACGGCGGACGACCTCTTCGCCTTCATCGACACCCAGCTCGGCCGTTCTGCGCACTGA	MANEQELREYLKKAIADARDARRQLREVEDKAQEPIAIVGMACRYPGGVSSPEDLWDLVANGVDAVSEFPSNRGWDVEKLYDPDPERPGTSYVREGGFLHDADLFDREFFGMSPREALAIDPQQRLLLETAWETFENAGIVPAALRGSRTGVFTGAMYNDYGSRPDLPAEGNEGYLFSGSAGSIASGRMAYTFGLEGPAVTVDTACSSSLVAMHLAVNALRNGECDLALAGGVAVMSTPTAFVEFSRLRGLSTDGRCRSFSEDADGTGWSEGVGLLLVERLSDARKNGHRVLAVIRGSAVNQDGASNGLTAPNGPSQERVILAALANAGLTTADVDAVEAHGTGTRLGDPIEAQALLATYGQGRPAGHPLYLGSLKSNIGHAQSAAGVGGVIKMIEAMRHGVLPRTLHVGEPSSHVDWDAGAVELLTEAREWPEVDGRPRRAGVSSFGFGGTNAHVVIEEPPAAPEEQDTTERTELPLIPWVLSGRSAQAVRDQAARLLTHLDTHPALTAQDIALSLATERTAFDHRAVVTGTDRTELLDAVRALAEGGGTEPSRVHGSGSTAFLFTGQGAQRLGMGRQLHAAFPAFATAFDEVAAALDPHLPRPINDVITDGDDLDRTEFTQPALFAIEVALYRLIHSWGITPDYVAGHSIGELAAAHVAGVFSLEDAARLVAARGRLMQAAREGGAMAAVQASQDEVAAALAEESGVVAVAAVNSPLSTVISGDAEAVERQVARWREHGRKAVRLAVSHAFHSPHMDDILDAFREVAATVTYHKPRIPLVSTLTGRLTDADELTTPQYWTDQIRGTVRFTDALTSLREAGAGVFVEIGPDAVLTALTRDTVEDATALPLLRRDHDETHTLISGVARAFTAGAPVDWSAFLGPATTTPAPLPTYAFQRERHWLDPVDAPADAEGLGLKAVGHPILGASLGLAARDEYVLTSRVSLRTHPWLADHVVLGATLLPGTAFVELCARAGDQVGAPRVEDLTLSAPLVLPARGGVQVQVVVGEADDAGRRGVEVYGRPEPDSDVDEAGEGPWTLHARGRLVPAEASAGEALTVWPPAGAREVSLEGAYERLEELGYTYGPAFQGLRRAWRGDGEVFAEVVLPEGPHAEAGQYLLHPALLDAALHTLLPGVVDPDREALVPFGWEGVTIHAVGAGTVRVRFSLGAVDSVALTVADGTGAPVASVEGLTLRPLSSEALRAAAAPNGPDGLFAVRWKPVPGGTAPAPDGAEVVEVVSGGRSAPEVLHDTLHGIQEFLTDDSKADHTLVVVTRGAVALEGEEIADLAAAGVTGLVRVAQTEHPGRIVLADLEPDTDLDASLILATGEPQLAVRDGVTYVPRLNRATGEPGERTVRWDEGTVLVTGATGTLGAVLARHLVTAHGARNLLLVSRRGPDAPGATELKDELRTLGAEATLAACDVSDKDSLADVLARIPADRPLKAVVHTAGVLDDTVLTDLTPERLDAVMAAKADAAWHLHELTQDLELSAFVLYSSIAGLIGNAGQANYAAANTYLDALAQHRAALGLPGVSLAWGLWNQTSTISGELGDADLQRIKRLGLLPLATDEAMELFDSAVAGTEPVLAVSRIDTAALRAQRQAPTPLLRALVPAGPRRANDTRSDAAASLAQRLGALSREEREQALVDLVRAQVAAVLGHTDAGAVDPQRAFQELGFDSLTAVELRNQLNGATGLRLPSTLVFDHPNPAALAAHLASELFGEEESVAVTADSASMEPIAIVGMACRYPGGVSSPEDLWDLVSGEVDAISEFPSNRGWDVEKLYDPDPEQYGTSYVREGGFLHDADLFDREFFGMSPREATATDPQQRLLLETAWETLENAGIVPTTLRGSRTGVFTGVMYHDYATATGTVPEELEGYLAAGSAGSVASGRLSYTFGLEGPAITVDTACSSSLVALHMAAGALRNGECDLALAGGATVMATPATFVEFSRQRGLSADGRCKSFSEDADGTGWSEGVGLLLVERLSDARKNGHRILAVIRGTAVNQDGASNGLTAPNGPSQERVIKQALANAGLNTDDVDAVEAHGTGTRLGDPIEAQALLATYGRNRTTDKPLYLGSLKSNIGHSQAAAGVGGVIKMIEAMRHGTLPRTLHADKPSSHIDWDAGAVELLTEAREWPEVDGRPRRAGISSFGISGTNAHVVIEEPPAAPEEQDTTERTELPLIPWVLSGRSAQAVRDQAARLLTHLETHPALTAQDIALSLATERAAFDHRAVVTGTDRTELIDAVRALAEGTGTQPAQTHRPGSTAFLFTGQGAQRLGMGRQLHAAFPAFATAFDEVAAALDPHLPRPISDVITDGDGLDRTEFTQPALFAIEVALFRLVHSWGITPDYVAGHSIGELAAAHIAGVFSLEDAARLVAARGRLMQAAREGGAMAAIQAAEDEVRASLLPYGEKRISVAAVNGPRATVISGDQDTVTKVMEDWQANGTRVKRLTVSHAFHSPHMDDILDEFQQVAATLTYHKPRIPLVSTLTGRLADADELTTPQYWTDQIRGTVRFTHALTTLHETGARVLIEIGPDAVLTALTRDTLDNTTALPLLRRDHDETHTLITGVAQAFTAGVPVDWSAFLGPATTTPAPLPTYAFQRERHWMERKDAVPADEARGGSSLGHPLLAAKVEPAGSEGVLFSGRVSVETHPWLETYTVLDAPVLPTAALVDLVVRAGDEVGLGTLDTLTVHTPLVLSALTPTEIQLAVAGPDESGLRAFTLYARPADEGARWTTYADGGLSVTAAQPVRAVGDGSGTEVALADELLPDAVRYGLHPGLLEAALRAAEEADAVAPARPGTVLVPAEWHDVRLHASGATVVRVQWQAVDRRTLAVRLTDAAGEPVLTVGRLVFQEVPYDRFAAAGRAALPLYRTEWGIAELPTAEAPLRWADLGPDGGDGTGTAYSTLSEAAEAIAAGAPVDALRVWAHDESGTDVVDALHRRTRDALALVQEYLADERLGDVPLAVVTRGAVAVGAEEVADLAGAGVRGLLRSAQAEAPGRIFLLDLERSAGGEGEPLAPDALLSAVVAADEPEAAVRDAGIRVPRLRRVDSTAAAPSVPPRSDADLPVPARSDADPSVPARSDARPSRPGFDRSPGGTVLITGGTGALGALVARRLVAEHGVRHLLLLGREGAAAPGAEALAEELTGAGATVTVTACDAGDRAALAAVLDGIPAEHPLTAVVHAAGVLDNALIADLGAPSLAGVLAAKADAAWHLHELTRDRDLSAFVLFSSSVGVLGGPGQANYAAANAFVDALAGLRAAQGLPATAIGWGVWDPAEIGGGINTALGESGHKRYTREGFRLIPAQEGLGLLDAALAEGVAHLVALPLDLAALRAHGRVPAALRDLVPAPGRRGAAHGVDAAGGADGRVSLEQRLAALPAEEREQAVLDLVRGEIAAALGHAGAHQVAAHRAFQDLGFDSLTAVDLRNRLTTATGLRLPSTLVFDHPNPEALAAHLLGRLDVGDTPGGTPAMAELDRLEAALLGTDAPDDEETRSAVTVRLKALLARMTAAETPEDDAADVTESIEAATADDLFAFIDTQLGRSAH	MTKKALFFAISTMFLSACSFNTVQQHQIQSISTNKNSEKIKSLFDQAQTEGVLVIKRGQIEEVYGNDPKRASTDYVPASTFKMLNALIGLEHHKATPTEVFKWDGQKRLFPDWEKDMTLGDAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNADIGSKVDDFWLVGPLKITPQQEAQFAYELAHKTLPFSKNVQEQVQSMLFIEEKNGRKIYAKSGWGWDVEPQVGWLTGWVVQPQGEIVAFSLNLEMKKGIPSSIRKEIAYKGLEQLGIL	1298.53	gnl|BL_ORD_ID|3791|hsp_num:0	4861			177	342	cloxacillin; oxacillin; cefalotin
BGC0001433.1|Argimycin_14 # 40845 # 47456 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.744	BGC0001433.1|Argimycin_14 	40845	47456	+	Loose	550	29.6462	KPC-7	31.17	3002317	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; penam	antibiotic inactivation	KPC beta-lactamase	ATGGCCACTGAGTCCAACGACCGGGCCCGGCAGACCCCCGCCGCCAAGGGACAGACCAACGAGGAGAAGCTGGTCGAGTACCTGAAGTGGGTGACCGCCGACCTGCACAAGGCCAAGCAGCGGATCACCGAGCTGGAGAGCGGTCAGGACGAGCCCGTCGCCGTCATCGGCATGGCGTGCCGCTACCCGGGCGGGGTGACCTCGCCCGCCGAACTGTGGAGGCTCGTCGCCGACGGGGTGGACGGCATCACCCCCTGGCCCACCGACCGCGGCTGGGACATCGAGGGCCTGTACGACCCGGAGCCCGGCAGGGCGGGCAAGTCCTACACCCGCGAGGGCGGATTCCTGGACGGGGCCGCCGAGTTCGACGCGGCCTTCTTCGGCATCTCACCGCGCGAGGCCCTCGGCATGGACCCGCAGCAGCGCGTCCTGCTGGAGACGGCGTGGGAGGCGCTGGAGAGCGCCGGCCTCGACCCGGCCGCCCTCAGGGGCAGCCGCACCGGCGTGTTCGCCGGCCTGGTGGAACAGAGCTACCTCGACCGCGAGGGCCCCGAGGAGCTCGAGGGCTACCTCATGACGAGCAAGCTCTCCAGCGTGGCCTCCGGCCGGATCGCCTACACCTTCGGCCTGGAGGGCCCGGCCGTCTCCGTGGACACGGCCTGCTCCTCCTCGCTGGTGGCCCTGCACATGGCGGTGCAGTCGCTGCGCTCGGGCGAGTCCACGCTCGCCCTCGCGGGCGGCGTCACCGTCTCCGGTTCCCCGAGCGGCTTCGTGGACTTCTCCCGCCAGCGCGGCCTGTCCGCCGACGGCCGCTGCAAGTCCTTCTCCGACGACGCCGACGGCACCGGCTGGTCCGAGGGCGTCGGCATGCTCCTCGTCGAGAAACTCTCCGACGCGCGGAAGAACGGCCACCGGATCCTGGCGGTGATCCGCGGCACGGCCGTCAACCAGGACGGGGCCAGCAACGGGCTGACCGCCCCCAACGGCCCCTCCCAGGAACGCGTCATCAAGCAGGCCCTCGCCAACGCCGGTCTGACCACGGCCGACGTGGACGCCGTCGAGGCCCACGGCACCGGCACCCGCCTCGGCGACCCCATCGAGGCCCACGCGCTGCTCGCCACCTACGGTCAGGGGCGTCCCGCCGGGCGCCCGCTGTACCTCGGCTCGCTCAAGTCGAACATCGGTCACTCGGTCGCCGCGGCCGGAGTGGGCGGCGTGATCAAGATGATCGAGGCGATGCGGCACGGGGTGCTGCCGAAGACCCTCCACGCGGACAAGCCGTCCAGCCACATCGACTGGGACGCCGGTGCGGTGGAGCTGCTGACCGAGGCACGCGAGTGGCCCGAGGTCGACGGCCGCCCGCGCCGCGCGGGCGTCTCCGCCTTCGGCGTGAGCGGCACCAACGCGCACGTCATAGTCGAGCAGGCCCCCGCCGAGGACGCCCCGGAAGCCGACCCGGCCGAGTTCGCCCTCCCTGTCGTTCCCTGGGTGCTGTCGGGCAGGAGCGCGCAGGCGGTCCGTGACCAGGCAGCCCGCCTGCTGACCCACCTGGAGACCCACCCCGCCCTCACCGCACAGGACATCGCCCTGTCCCTGGCCACCGAACGCGCCGCCTTCGACCACCGCGCGGTGGTCACGGGCACCGACCGCACCGAACTCCTCGACGCCGTAAAGGCGTTGGCGGAGGGCGGCGGTACGGAACCGTCACGAGTGCACGGTTCGAGCTCCACCGCCTTCCTGTTCACGGGGCAGGGAGCACAACGGCTCGGAATGGGACGGCAACTGCACGCGGCGTTCCCGGCGTTCGCCACCGCCTTCGACGAGGTCGCCGCCGCCCTCGACCCCCACCTGCCCCGCCCGATCAACGACGTCATCACCGACGGCGACGACCTGGACCGCACCGAATTCACCCAACCCGCCCTCTTCGCCATCGAAGTCGCCCTCTACCGCCTCGTCCACTCCTGGGGCATCACCCCCGACTACGTCGCAGGCCACTCCATCGGCGAACTCGCCGCCGCCCACATCGCCGGAGTCTTCTCCCTCGAAGACGCCGCACGACTCGTCGCCGCCCGCGGACGCCTCATGCAAGCCGCCCGCGAAGACGGCGCCATGGCCGCCATCCAGGCCACCGAGACAGAAGTCCGCACCTCCCTGCTCCCCTACGGCGAGGAACGGATCTCCATCGCCGCCGTCAACGGCCCCCGCGCCACCGTCATCTCCGGCGACCAGGACACCGTCACCAAGGTCATGGAGGACTGGCAGGCCAACGGCACCCGCGTCAAACGCCTGACCGTCTCCCACGCCTTCCACTCCCCCCACATGGACGACATCCTCGACGCCTTCCGGGAAGTCGCCGCCACCGTCACCTACCACAAACCCCGCATCCCCCTCGTCTCCACCCTCACCGGACGCCTCACCGACGCCGACGAACTCACCACCCCCCAGTACTGGACCGACCAGATCCGCGGCACCGTCCGCTTCACCCACGCCCTCACCAGCCTGCGCGAAGCCGGGGCGGGCGTCTTCGTCGAGATCGGCCCCGACGCCGTCCTCACCGCCCTCACCCGCGACACCCTCGACAACACCACCGCCCTCCCCCTCCTCCGCCGCGACCACGACGAAGCCCGGATCCTCGTCCAGGCCGTCGGCGCCCTGCACACCCAGGGCGTCCGAGTGGACTGGACGGCCTTCTTCGCCGGTACCGGCGCCCGCCGCGTCGAGTCGCCCCTGCCCACCTACGCCTTCCAGCACGAGCGGTACTGGATCAAGTCCGTCGCCGGTGCCCTGGACACCGCCGGCCTCGGTCTCCGGCCGGGCGGACACCCGGTCTTCGGCGCCCAGGTGGAACAGGCGGACGGCCGGGGCGCGCTGTTCACCGGCCGCGTCTCGGTGCGCAGTCACCCGTGGCTGACCCGGTACACCCTCCTCGGAGCGACCGCGCTGCCGCCGGAGGCCCTGGTGGACGCCCTCGTGCGCGCCGGCGACGAACTCGGCACGGGCACCGTGGAGTCACTGGTCCTGGACCTGCCGCCGACGCTGCCGGAGGACGGCCGGCTCCAGCTCCAGCTGTCCGTCGGGGAACCGGACGCGGACCTGACGCGGGCCTTCACCCTGTACGCCCGCCCCGACGGCGGCGACCTGCCGTGGTCGGAGTGCGCGCGGGGACGGCTGGGCCACGGCGGCTCCAGGGCGCCGTTCGCCCCCTCGGCCGCGTGGCCGCCCGCCGAGGCCGCCGCGCTCGCCCTCGGGGACACGGACACGGACCGGGGCGTCACCGCCGGCTGGCGGCTCGGCGACGAGGTGTTCGCCGACCTCGTCCTCGACGAGGCCCTGCACGGCGAGGCCGCCGACTTCGGCCTGCACCCGGAACTGCTGCGCTCGGCCCTGTACGCCGCGGCGCTGACCGGCCCGCACGGGGAACGGGACGACGAGACGCTCGCCGTCGAGTGGAGCGGCTTCCAGCTGTACGCGACCGGTGCCACCGCCCTGCGCGCCCACCTCGTCCCTACGGGCGAGCACACGGTCGCCGTGCGTCTCGCCGACCGGGCCGGCCGGCCCGTGGCCTTCGCCCGGGCCGTGACCAGCCGCTCCGTGGACGCCGGCCGGGTGCGTGACGCCCTGGCCCGGGACGCCGACGCGTTGTTCCGCGTGGACTGGCGGGCCACCCCGCTGCCCGTGCCCCCCACCGCCCCGGTCCTCGCCGTCGTCGGCGAGGACTTCGACCGCCCCACCGCCGCCCCCGCCGGCGAGGGAGCCGACCGCACCCGCGAGGGAGCCGACCGCCTCACCCTGGCCGAGGCGACCGGGCGGGCCGGGCGCGGCGAGGCCGACGCGGTCGTGGTGTTCAGGCCCGCCGTCGACCCGCGGGGCGCGGATGTCGTGGCCACCGTGCACGCGCGCACCCGCGCCACCCTGGGCCTGGTCCAGCGGTGGCTGGCCGACGAGCGGCCCGGCGCCGTACCACTGGTCGTGGTGACCCGGGGCGCCGTCGCCACCGGGGACGAGGAGTTCCTCGACCCGGCCGGCTCGGCGGACTGGGGTCTGCTGCGCTCGGCGCAGTCGGAGTCCCCGGACCGGATCGTCCTGGTGGACGTCGACACGGACGATCCGGACGCCCTCGCGGGCCCCCTGGCCGCGGTGGTCGCCTCCGGCGCCGCCCAGGCCGCGATCCGCGACGGCCGCGTCCTGCTGCCGAGCGTGCTCCGAGCCCCCGGCGCCCCCCGTGCCGAGGACGACGGCGCCCGCCGCTGGAACCCCGAGGGCACGGTCCTGATCACCGGTGGCACCGGCAGTCTCGGCGCCCTCTTCGCCCGCCACCTGGCGGGCGAGCACGGGGTGCGGCACCTGCTCCTGGTCAGCCGCCGGGGGCCCGCCGCGCCGGGCGCCGAGGAGCTGCGGGCGGAACTGGCCGGGCTGGGCGCCACGGCGACCGTCGTCGCCGCCGACATCGCCGACCGTACCGCTCTGGCCGCCGTCCTCGACGCGGTGCCCGCCGAGCACCCGCTGACCGGTGTCCTGCACCTGGCCGGTGTCACCGACGACGGTCTGGTCGGCGACCTCACCCCGGAGCGTCTCGACGCCGTGCTGGCGCCCAAGGCCGACGCCGCCTGGCACCTGCACGAACTGACCGAGCGGCTGGACCTGTCGGCCTTCGTGCTGTTCTCCTCGGTCGCGGGGGTCATCGGCGGCGCCGGCCAGGCCAACTACGCGGCGGCCAACGCCTTCCTGGACGGACTCGCCGCCCTGCGCGCCGCCCGGGGCCTGCCCGCCACCTCCGTGGCCTGGGGGCTGTGGGCCCAGGACTCCGGCATCGCCGGCGACCTCGACGAGGCCGACATCGCCCGCATCACCCGCGCCGGCTTCGGCGTCATCTCCCCCCAGCAGGGCCCGCGGCTGCTGGACCTCGCCCTCGCCCTGCCGTACGCCGCCCCCGTCGTCACCCCGCTGGACCTCGCCGCGATGCGGGAGCGTCCCGCGCAGGCGCCGCCGCTGTTCGCCTCCCTGGTGCGCAGGCCGGTGCGGCGCGCCGCCAACAACTCCGAGCGCACGGCGGACGGTCTGGCGCGGCGCCTGGCCGCGGCCGACGAACGCGAACAGCTCGCCCTCGTCCTGGAGGTGGTGCTCACCGCCACGGCGGCGGTCCTCGGCCACGGCGACCCGTCGTCCCTCGCCGTCGAACAGCCCTTCAGCGGGCTCGGGTTCGACTCCCTCACCGCGGTGGAACTGCGCAACCGCCTCGCCGCGGAACTGGACCTGCGCCTGCCCGGCACCCTGGTCTTCGACCACCCCACCCCCCGCGCCCTGGCGGAGTTCCTGCGGACCGCTCTGACGAACGGCGCGGACGGCGCCGACGGCACGGGCGGCGACACGGCCGCGGCAGCGGCCGGCCGGCAGGGGGAGGACTACGCGGCGGAGATCCGCCTGGACGAGGCGATCCGGCCCGCCGCCGAGGTCGTACGGCAGGTCGACGACCCGGCGGAGATCTTCCTGACCGGCGCCACCGGCTTCCTCGGCGCGTTCCTGCTGCGCGACCTGTCGCGCGCCACCCGGGGCACCCTGCACTGCCTGGTCCGCGCGCGCGACGCGGCCGACGGCCTGCGGCGGCTGCGCGAGAACCTGGAGTACTACCGCGTCTGGGACGAGGTGGACCCCGCACGGATCAAGGTGGTCGTCGGCGACCTCGCCGAGCCCCGGTTCGGCCTGGACGAGGAGGAGTTCGACGCCCTCGCCCGCACCGTCGACGTCGTCTACCACGGCGGCGCCCAGGTGCACTGGCTGCACCCGTTCAGCACGCTGAAGGCGGCCAACGTGGGCGGCACGCGGGAGGTCCTGCGGCTCGCGGCACGGCACCGCACCGTTCCGGTCCACTACCTGTCCACCACCGGCGTCTTCGCGGGCCAGGGGACGGGAGGCCGTCCGCTGAAGGTGGACGACCCCACCGGGCCGGCCGAGGCGCTGCCCAGCGGCTACCTGCGCAGCAAGTGGGTCGCCGAGCAGGTCGTCGGGATCGCCCGCGACCGGGGTCTGCCGGTCTCCGTCTACCGCGTGGACGTCGTCTCGGGCGACCAGGTCAACGGCGCCTGCCAGACCCGCGACTTCGTCTGGCTGAGCCTGCGCGGGCTGATCCAGGCGGGCGCCGTCCCGGCCGGCCTGGACGTCGCGGTCCCGCTCACGCCCGTGGACTACGTCAGCTCCGCGCTGGTCGCCCTGTCGCTGTCGGGGCGGGTCCGGCCGGGCACCTTCCATCTCTACAACCAGAGCCACATGACCTTCGCCGAGTTCGTCACCGAGCTGAGGGCGAGGGGCCACTCGCTGGAGGAGCTGGACCGGGACTCCTGGAGCGCCCTGGTGCGGTCGGACCCCGACAACGTGATGCTTCCGCTGCTGGAGGCCTTCGAGATGATGGCGAGGGGTGACGGGACCTTCTACCCGCCGGTCGACACGAGCGTGGCCGAACGGGCGCTGGCGGACACCGGGATCGAGTGCCCGAAGATGACGGTCGACCTGTTCCGGCGGTACGTCACCTTCTTCACGGAAGCCGGTTTCCTCCCTCCGGCGGACGCGGCCGCGCAGCCGGTGGACGCGGCCGCGCAGCTCTCCGCCCGCTCCTGA	MATESNDRARQTPAAKGQTNEEKLVEYLKWVTADLHKAKQRITELESGQDEPVAVIGMACRYPGGVTSPAELWRLVADGVDGITPWPTDRGWDIEGLYDPEPGRAGKSYTREGGFLDGAAEFDAAFFGISPREALGMDPQQRVLLETAWEALESAGLDPAALRGSRTGVFAGLVEQSYLDREGPEELEGYLMTSKLSSVASGRIAYTFGLEGPAVSVDTACSSSLVALHMAVQSLRSGESTLALAGGVTVSGSPSGFVDFSRQRGLSADGRCKSFSDDADGTGWSEGVGMLLVEKLSDARKNGHRILAVIRGTAVNQDGASNGLTAPNGPSQERVIKQALANAGLTTADVDAVEAHGTGTRLGDPIEAHALLATYGQGRPAGRPLYLGSLKSNIGHSVAAAGVGGVIKMIEAMRHGVLPKTLHADKPSSHIDWDAGAVELLTEAREWPEVDGRPRRAGVSAFGVSGTNAHVIVEQAPAEDAPEADPAEFALPVVPWVLSGRSAQAVRDQAARLLTHLETHPALTAQDIALSLATERAAFDHRAVVTGTDRTELLDAVKALAEGGGTEPSRVHGSSSTAFLFTGQGAQRLGMGRQLHAAFPAFATAFDEVAAALDPHLPRPINDVITDGDDLDRTEFTQPALFAIEVALYRLVHSWGITPDYVAGHSIGELAAAHIAGVFSLEDAARLVAARGRLMQAAREDGAMAAIQATETEVRTSLLPYGEERISIAAVNGPRATVISGDQDTVTKVMEDWQANGTRVKRLTVSHAFHSPHMDDILDAFREVAATVTYHKPRIPLVSTLTGRLTDADELTTPQYWTDQIRGTVRFTHALTSLREAGAGVFVEIGPDAVLTALTRDTLDNTTALPLLRRDHDEARILVQAVGALHTQGVRVDWTAFFAGTGARRVESPLPTYAFQHERYWIKSVAGALDTAGLGLRPGGHPVFGAQVEQADGRGALFTGRVSVRSHPWLTRYTLLGATALPPEALVDALVRAGDELGTGTVESLVLDLPPTLPEDGRLQLQLSVGEPDADLTRAFTLYARPDGGDLPWSECARGRLGHGGSRAPFAPSAAWPPAEAAALALGDTDTDRGVTAGWRLGDEVFADLVLDEALHGEAADFGLHPELLRSALYAAALTGPHGERDDETLAVEWSGFQLYATGATALRAHLVPTGEHTVAVRLADRAGRPVAFARAVTSRSVDAGRVRDALARDADALFRVDWRATPLPVPPTAPVLAVVGEDFDRPTAAPAGEGADRTREGADRLTLAEATGRAGRGEADAVVVFRPAVDPRGADVVATVHARTRATLGLVQRWLADERPGAVPLVVVTRGAVATGDEEFLDPAGSADWGLLRSAQSESPDRIVLVDVDTDDPDALAGPLAAVVASGAAQAAIRDGRVLLPSVLRAPGAPRAEDDGARRWNPEGTVLITGGTGSLGALFARHLAGEHGVRHLLLVSRRGPAAPGAEELRAELAGLGATATVVAADIADRTALAAVLDAVPAEHPLTGVLHLAGVTDDGLVGDLTPERLDAVLAPKADAAWHLHELTERLDLSAFVLFSSVAGVIGGAGQANYAAANAFLDGLAALRAARGLPATSVAWGLWAQDSGIAGDLDEADIARITRAGFGVISPQQGPRLLDLALALPYAAPVVTPLDLAAMRERPAQAPPLFASLVRRPVRRAANNSERTADGLARRLAAADEREQLALVLEVVLTATAAVLGHGDPSSLAVEQPFSGLGFDSLTAVELRNRLAAELDLRLPGTLVFDHPTPRALAEFLRTALTNGADGADGTGGDTAAAAAGRQGEDYAAEIRLDEAIRPAAEVVRQVDDPAEIFLTGATGFLGAFLLRDLSRATRGTLHCLVRARDAADGLRRLRENLEYYRVWDEVDPARIKVVVGDLAEPRFGLDEEEFDALARTVDVVYHGGAQVHWLHPFSTLKAANVGGTREVLRLAARHRTVPVHYLSTTGVFAGQGTGGRPLKVDDPTGPAEALPSGYLRSKWVAEQVVGIARDRGLPVSVYRVDVVSGDQVNGACQTRDFVWLSLRGLIQAGAVPAGLDVAVPLTPVDYVSSALVALSLSGRVRPGTFHLYNQSHMTFAEFVTELRARGHSLEELDRDSWSALVRSDPDNVMLPLLEAFEMMARGDGTFYPPVDTSVAERALADTGIECPKMTVDLFRRYVTFFTEAGFLPPADAAAQPVDAAAQLSARS	MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAIDTGSGATVSYRAEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAELSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTSSPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVYGTANDYAVVWPTGRAPIVLAVYTRAPNKDDKYSEAVIAAAARLALEGLGVNGQ	751.88	gnl|BL_ORD_ID|1724|hsp_num:0	1866			84	315	
BGC0001433.1|Argimycin_15 # 47550 # 48323 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.756	BGC0001433.1|Argimycin_15 	47550	48323	+	Loose	500	28.4906	APH(3')-IIb	31.91	3002645	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	ATGTCCGTAGTGGAGAGCCGCTGGCTGCGGCGGTTCGCAGGCGCCGAGGGCGGTGGGGGCGGCGAGAGCGGCCGGCTCCAGCTCGTCTGCTTCCCGCACGCGGGCGGCGCGGCCAGCGCCTACCTGGGCCTGACCCGGGCCCTGGCGCCCGACATCGACGTGGTGGCCGTCCAGTACCCGGGGCGCCAGGAGCGCAGGCTGGAGCCCGCGCTGACCTCCCTGACCCATCTGGCGCGGGCCGTCGCCGAGGAACTGGCCCGCGTGCCGCAGCGCCCGTACGCGTTCTTCGGCCACAGCATGGGCGCGGTCGTCGCCTACGAGACGGCCCGCGTGCTGGCCGAGTTCGACCTGGTCACCCCGCGGCGGCTGATCCTCTCCGGGCGCGGCGCCCCGAGCCTGAAGCCCCGGGCGAGCGACCGCCTGGAGGGCGACGCGGCCCTGATCGCCGAGATCCGCCGCCTGGGCGGCACGGGCAGCCGGGTCCTGGACGACCCCGAACTGCTGGAGATGGTGCTGCCCACCCTCCGCGCCGACTACGGGGCCCTCAGCCGCTACCGCTGGCTGCCGGGACCGCCCCTCGACGTCCCACTGACCGTCATGGTCGGCACCGCCGACCCGGTCGTCCCGGTCGACGACGCCCGTGGCTGGCTCGCCCACTCCACGCGCCCGGGCGAACTCCTCACCTTCGACGGCGGCCACTTCTACCTCGACACCCGGCTCCCGTCGGTGGCGGAGGCGCTGCGCACGCTCCTCGGACAGCCCACGAGGGTGTGA	MSVVESRWLRRFAGAEGGGGGESGRLQLVCFPHAGGAASAYLGLTRALAPDIDVVAVQYPGRQERRLEPALTSLTHLARAVAEELARVPQRPYAFFGHSMGAVVAYETARVLAEFDLVTPRRLILSGRGAPSLKPRASDRLEGDAALIAEIRRLGGTGSRVLDDPELLEMVLPTLRADYGALSRYRWLPGPPLDVPLTVMVGTADPVVPVDDARGWLAHSTRPGELLTFDGGHFYLDTRLPSVAEALRTLLGQPTRV	MHDAATSMPPQAPSTWADYLAGYRWRGQGEGCSAATVHRLEAARRPTLFVKQEVLSAHAELPAEIARLRWLHGAGIDCPQVLNETQSDGRQWLLMSAMPGDTLSALAQRDELEPERLVRLVAAALRRLHDLDPAACPFDHRLERRLDTVRQRVEAGLVDEADFDDDHRGRSATELYRLLLDRRPAVEDLVVAHGDACLPNLLAEGRRFSGFIDCGRLGVADRHQDLALAARDIEAELGAAWAEAFLVEYGGDIDGERLAYFRLLDEFF	95.90	gnl|BL_ORD_ID|875|hsp_num:0	954			192	312	neomycin; ribostamycin; butirosin; kanamycin A; gentamicin B; paromomycin; gentamicin
BGC0001433.1|Argimycin_16 # 48574 # 49107 # -1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.685	BGC0001433.1|Argimycin_16 	48574	49107	-	Loose	1300	29.261	mdtO	41.86	3003549	protein homolog model	n/a	n/a	nucleoside antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCCCCGCCTTGCGCTGTACACCTTCGGCGTCCTGACATCACCTCTCGCCGGTCCCGCACCTCTCACGCGCGAGTTCTACGACATCGGTGAGACCGTCTACCGGGAGATCAGTCAGCACCCCGGACACCTCGCGCGTGCTGAAGCGGCGGACGGTGACCGGGGCGCGCTCTTCGAGGCGGACTGGGGCGCATGGGGAGAGTTCGCCGTACCGACCTGGTACGACAAGGGCCGTACGCCGGAAACCACCGCCCTGGCCGCGTCCCTCTCCCTCTGGACCGGCCTGCGCCCCGCCTTCGACGCCGTCTACACCGGTCCGCACCGTGAGGCGCTGAAAAGGCGTCACGACTGGTTCGAGAGGACGGGGCACCCGAATCACGTGTTCTGGTGGGTCTCCGACGGCGTGACACCCACCTGGCAGGACGGGGTTTCCCGGCTGGAGCACCTCCACGACCACGGCTCCGCGCCGCACGCCTTCACCTTCCACGACTCGTTCGCCCCGGACGGGACTCCGGCCAGGATCAGAGGAATCTGA	MPRLALYTFGVLTSPLAGPAPLTREFYDIGETVYREISQHPGHLARAEAADGDRGALFEADWGAWGEFAVPTWYDKGRTPETTALAASLSLWTGLRPAFDAVYTGPHREALKRRHDWFERTGHPNHVFWWVSDGVTPTWQDGVSRLEHLHDHGSAPHAFTFHDSFAPDGTPARIRGI	MSALNSLPLPVVRLLAFFHEELSERRPGRVPQTVQLWVGCLLVILISMTFEIPFVALSLAVLFYGIQSNAFYTKFVAILFVVATVLEIGSLFLIYKWSYGEPLIRLIIAGPILMGCMFLMRTHRLGLVFFAVAIVAIYGQTFPAMLDYPEVVVRLTLWCIVVGLYPTLLMTLIGVLWFPSRAISQMHQALNDRLDDAISHLTDSLAPLPETRIEREALALQKLNVFCLADDANWRTQNAWWQSCVATVTYIYSTLNRYDPTSFADSQAIIEFRQKLASEINKLQHAVAEGQCWQSDWRISESEAMAARECNLENICQTLLQLGQMDPNTPPTPAAKPPSMAADAFTNPDYMRYAVKTLLACLICYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMVLRFGGAFCGAILALLFTLLVMPWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGPVYDLVEIRDRALGIIIGTVVSAVIYTFVWPESEARTLPQKLAGTLGMLSKVMRIPRQQEVTALRTYLQIRIGLHAAFNACEEMCQRVALERQLDSEERALLIERSQTVIRQGRDLLHAWDATWNSAQALDNALQPDRAGQFADALEKYAAGLATALSRSPQITLEETPASQAILPTLLKQEQHVCQLFARLPDWTAPALTPATEQAQGATQ	25.92	gnl|BL_ORD_ID|1893|hsp_num:0	2056			1581	1710	acriflavine; puromycin
BGC0001433.1|Argimycin_17 # 49693 # 50325 # -1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.722	BGC0001433.1|Argimycin_17 	49693	50325	-	Loose	375	38.891	Escherichia coli AcrAB-TolC with AcrR mutation conferring resistance to ciprofloxacin, tetracycline, and ceftazidime	39.53	3003807	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCCGACATCAAGCACTTCGATCCGGACGTGGCCTTGGAGACCGTGGTACGGCTCTTCTGGCGGCAGGGCATGGCCTCGACCGGTATCCAGGACGTGGTGACGGCCACCGGCGTCAACCGCTCCAGCCTCTACTCCACCTTCGGTGACAAGCGGGCGCTGTACCGGGCCGCCCTGCGTCGCTACCTCGAGCACCGCTCCCAACCGGTGTTCCAGCGCCTCGCCGAGGACGGCAGGGGGCTGCCGGCCATCACCGAGTTCTTCACCGGGCTCATCTCGGCACGCTGCTCGGGTGAGTACGCCGGTTGGGGCTGCATGGTCTCCAACGCCCAAGCGGGGACCGAGAACGCCGACCCCGAGGTCCGCGCCCTCCTCGACCGGCACCACCAGCAGCTGCGCGACGCCATGTACGCGGCGCTGGTCGCCGCCGAGGAGCAGGGGCAACTCGCCGTCGGCGCCGATCCGGGAGCCTCCGCCGACCTGCTGGCCCTCCTCGCGTACGGGGTCAACCTGCGCTCGCGGGCCGGAGCCGACGCGCACACCCTCGCGGACACCGTGAACGCCGCCCTGGGACCGATCAGCGCCCCGGCGGCGGCCCGGGCCGTCCGGGCCGCCGGGCGAAGCGTTCGGTGA	MSDIKHFDPDVALETVVRLFWRQGMASTGIQDVVTATGVNRSSLYSTFGDKRALYRAALRRYLEHRSQPVFQRLAEDGRGLPAITEFFTGLISARCSGEYAGWGCMVSNAQAGTENADPEVRALLDRHHQQLRDAMYAALVAAEEQGQLAVGADPGASADLLALLAYGVNLRSRAGADAHTLADTVNAALGPISAPAAARAVRAAGRSVR	MARKTKQEAQETRQHILDVALRLFSQQGVSSTSLGEIAKAAGVTRGAIYWHFKDKSDLFSEIWELSESNIGELELEYQAKFPGDPLSVLREILIHVLESTVTEERRRLLMEIIFHKCEFVGEMAVVQQAQRNLCLESYDRIEQTLKHCIEAKMLPADLMTRRAAIIMRGYISGLMENWLFAPQSFDLKKEARDYVAILLEMYLLCPTLRNPATNE	97.67	gnl|BL_ORD_ID|2090|hsp_num:0	2306			48	177	tigecycline; ciprofloxacin; tetracycline; ceftazidime; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0001433.1|Argimycin_20 # 51962 # 53107 # -1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.697	BGC0001433.1|Argimycin_20 	51962	53107	-	Loose	600	26.1794	Streptomyces venezuelae rox	48.39	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGAGGACCGAGTCCTACGACGTCGTGGTGGTCGGCCTGGGAGGCGTCGGCAGCGCTGCCGCACGGTCGCTCGCCGTCTCGGGCAAGCGGGTTCTGGGACTCGAACGCTTCGGCCCCGTGCACAACCTCGGTGCCAGCCACGGGGAGTCCCGCGGGGTGTGGCAGGCGTACTTCATGGGGCCCGGGTACGTACCCCTGCTGCGCCGCGCGCGCACGCTGTGGAGCGAGCTGGAGGAGGAGAGCGGAGAACGGCTGTTCCACCAGACGGGCGGCATGTGCCTGGGCCCCGCCGAAGGCGAACTGATCCCGGCCGCGCGGGCCAGCGCCGAGCAGTGCGGACTGCCCCACGAGTACTGGACGGCGGACCAGGTCCACGCCCACTATCCGCAGTTCACCCCCGCCGACGACTGCGTGGCCGTCTACGACCCGGAGTCCGGATACGTCCAGCCGGAACAGACCGTCCGGGTACAGCTGGGCCTCGCCGGGAAACACGGTGCCGAGCTGCACTTCGACGAGCAGGTCCTGGAGATCACCGAGACCTCCGGCGGGGTCAGGATACGGACCGACCGGACGGTCTACCACGCCGAGCACGTGGTGGTGTCGGCAGGCTGCTGGGCTCCCGGCCTGCTTCCCGGAATGGCGATCCCCATCAGCGTATTGCGCAAGGTGATGCTCTGGTTCGAACCCGAAGGGGACATGGCGGACTTCTTGCCCGGCCGCTTCCCGTACTGGATCTGGGAGGGAGGCGGAATGATCGGATACGGGCACCCGGCTGCCAACGGAACGCACGGCGGGGTGAAGGCGGGAGTGCACAGCGGCGGCACCCCGGCCGACCCCGACTCCGTCGAGCGGTTCGTCGACCAGCAGGAGGTTCAGGAGATCCAGTCCTTCCTGCGCGACCGCATCCCCGGACTCGGCAGGGGACGCTACCGCCAGAGCGCCGTGTGCCTCTACGACAACACCCCGGACCAGGCCTTCCTGATCGGCCCGGCGTCCGACGAGGGCCGGATCCTGCTCGCGGCCGGCACGTCGGGACATGCGTTCAAGTTCCTGCCTGCCATCGGCGAGGCCCTCGCCGAGCTCGTCACGGACGGCAGGACCCGGCAGGACCTGTCACTCTTCGCCCCCGGGCGATTCACCCCCTGA	MRTESYDVVVVGLGGVGSAAARSLAVSGKRVLGLERFGPVHNLGASHGESRGVWQAYFMGPGYVPLLRRARTLWSELEEESGERLFHQTGGMCLGPAEGELIPAARASAEQCGLPHEYWTADQVHAHYPQFTPADDCVAVYDPESGYVQPEQTVRVQLGLAGKHGAELHFDEQVLEITETSGGVRIRTDRTVYHAEHVVVSAGCWAPGLLPGMAIPISVLRKVMLWFEPEGDMADFLPGRFPYWIWEGGGMIGYGHPAANGTHGGVKAGVHSGGTPADPDSVERFVDQQEVQEIQSFLRDRIPGLGRGRYRQSAVCLYDNTPDQAFLIGPASDEGRILLAAGTSGHAFKFLPAIGEALAELVTDGRTRQDLSLFAPGRFTP	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	80.04	gnl|BL_ORD_ID|4833|hsp_num:0	5820			3	96	rifampin; rifaximin; rifapentine
BGC0001433.1|Argimycin_21 # 53836 # 55113 # -1 # ID=1_21;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.672	BGC0001433.1|Argimycin_21 	53836	55113	-	Loose	1050	26.1794	YojI	27.59	3003952	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGTTCGACGTCATAGGTGTGGGTTTCGGCCCCTCCAACGTCGCCCTGGCGATAGCGCTCGGAGAGGGCTCCGGGCGTGCGCTCACCGCGCATTTCTTCGAGAAGCAACCGCGATTCTCATGGCACCCCGGGATGCTCCTGCCGGAGGCCACCATGCAGGTCCATTTCCTCAAGGACCTGGTCACTTTGCGTGATCCGTCCAGCAAGTTTTCGTTCCTCAATTACCTGCATGAACAGGGCCGTCTCGTCGACTTCGTCAATCACAAGATGATCTTCCCGAGCAGGGTGGAGTTCCACGACTATTTCCGATGGTGCGCGAGCGCATGCGCGGACAAGGTCACCTATGGGTGCGAAGTGCTGTCGGTCGAACCGGTCGGCGGGGTGGAGGGCGGCCGGCTCCTGGACGTGCACCTGCGCCAGACCGACGAGTTGGGCACCCGTACCCTGCGGCGTCGCACCCGGAACGTGGTGATCGCCCCCGGACTGCGCAGGCGGCTGCCGGACGGCGTGGCCGAATCCGGCAGGGTGTGGCACAGCAGCGGGCTGCTCCAGCGCCTCGACGGGCTGCCGCCGGGGGGCGAAGGCCTGCGGTTCGCCGTGGTCGGAGCGGGCCAGAGCGCCGCCGAGGTGACCGCCCATCTGCACGACCGCTTCGACGGCGCACGAGTGCGCGCGGTGTTCACACCCTACGGATACGCTCCGGCGGACGACTCGCCCTTCGCCAACCGCATCTTCGACCCGGCCGCCGTCGACGACTTCTTCGGGGCCCCGCCCGCAGCCCGCAAGATGCTCTTCGAGCGCCACAAGAACACCAACTACGCGGTTGTCGACCAGGAGTTGATCGAGAACCTGTACGCCACCTGGTACCAGGAGAAGGTCCGGGGCGAGCAACGACTGCTGATCGACAACGCCACTCGGCTCCTGGAATGCGACGAGTCGCAGGACACCGTGCGCCTCACGCTGGAATCCCTGATCACCAGCGAGAAGACAGAGGTGGAGTGCGACTACCTCGTCTGTGCCACGGGATACCACCCGGCCGCCCCGGACGAACTGCTCGGACCGGATCTGCGTCGGCTGTGCCGCAAGGGCTCCCTGGGGCAGCCGCGGGTGGGACGCGACTACCGGCTGGAGATGGTCGACGGCGTCGAGTGCGGCATCTACGTCCAGGGCTCCACCGAGCACACGCACGGGCTCACCTCGACCCTGCTGTCCATGACCGCCGTCCGGGCAGGCGAGATCGCCGACGCGCTGCGCGACCGCCTGCACCGCGCCTCCTGA	MFDVIGVGFGPSNVALAIALGEGSGRALTAHFFEKQPRFSWHPGMLLPEATMQVHFLKDLVTLRDPSSKFSFLNYLHEQGRLVDFVNHKMIFPSRVEFHDYFRWCASACADKVTYGCEVLSVEPVGGVEGGRLLDVHLRQTDELGTRTLRRRTRNVVIAPGLRRRLPDGVAESGRVWHSSGLLQRLDGLPPGGEGLRFAVVGAGQSAAEVTAHLHDRFDGARVRAVFTPYGYAPADDSPFANRIFDPAAVDDFFGAPPAARKMLFERHKNTNYAVVDQELIENLYATWYQEKVRGEQRLLIDNATRLLECDESQDTVRLTLESLITSEKTEVECDYLVCATGYHPAAPDELLGPDLRRLCRKGSLGQPRVGRDYRLEMVDGVECGIYVQGSTEHTHGLTSTLLSMTAVRAGEIADALRDRLHRAS	MELLVLVWRQYRWPFISVMALSLASAALGIGLIAFINQRLIETADTSLLVLPEFLGLLLLLMAVTLGSQLALTTLGHHFVYRLRSEFIKRILDTHVERIEQLGSASLLAGLTSDVRNITIAFVRLPELVQGIILTIGSAAYLWMLSGKMLLVTAIWMAITIWGGFVLVARVYKHMATLRETEDKLYTDFQTVLEGRKELTLNRERAEYVFNNLYIPDAQEYRHHIIRADTFHLSAVNWSNIMMLGAIGLVFWMANSLGWADTNVAATYSLTLLFLRTPLLSAVGALPTLLTAQVAFNKLNKFALAPFKAEFPRPQAFPNWQTLELRNVTFAYQDNAFSVGPINLTIKRGELLFLIGGNGSGKSTLAMLLTGLYQPQSGEILLDGKPVSGEQPEDYRKLFSAVFTDVWLFDQLLGPEGKPANPQLVEKWLAQLKMAHKLELSNGRIVNLKLSKGQKKRVALLLALAEERDIILLDEWAADQDPHFRREFYQVLLPLMQEMGKTIFAISHDDHYFIHADRLLEMRNGQLSELTGEERDAASRDAVARTA	77.70	gnl|BL_ORD_ID|4707|hsp_num:0	2424			267	441	microcin J25
BGC0001433.1|Argimycin_22 # 55626 # 55847 # -1 # ID=1_22;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.689	BGC0001433.1|Argimycin_22 	55626	55847	-	Loose	3000	25.0238	abcA	58.82	3003942	protein homolog model	n/a	n/a	cephalosporin; penam; peptide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	TTGGTGAGAGGTGCGGGTGAGCCACGGAAACAGTGCTTCCGGACGGCGATCGATGAGCCGTGGCCGGCGGCTCCCCTGAAACCGAACGGCCTGCCGCCCGGAACCCTCAACGCTTTTGACGGGGTCGACGGCAGCGGCAGGACCACCACCGTCCGGCTCGCCTTCCTCGAGAGCCGGGGAAGGGCGGTGCGTGGCTTCAAGCTGTCCTCGCGCGAGCCGTAG	MVRGAGEPRKQCFRTAIDEPWPAAPLKPNGLPPGTLNAFDGVDGSGRTTTVRLAFLESRGRAVRGFKLSSREP	MNESHEAGKNSSTNVEEREEEVLRLARQFTEQSSYSTAGQTPFAAEAGSALDPNGERFNARAWCKAMLQMHIGDKEAHPLRTLGVAFSNLNVHGFGSDTDYQKSVGNVWLKTLSLARIAFGQKQRKVDILQNLEGLVEAGEMLVVLGPPGSGCSTFLKTIAGETYGFHVDKNSNINFQGIAKQMAHEFRGEAIYTAEVDVHFPKLTVGDTLYFAARARTPRHIPGGVNATQYAGHMRDVIMAMFGISHTKNTIVGNDFIRGVSGGERKRVSIAEACLSNAPLQCWDNSTRGLDSANAIEFCKTLRMQADINGTTACVSLYQAPQAAYDYFDKVLVLYEGREIYFGPTSMAKHYFLQMGFVCPDRQTDADFLTSMTSHLERVVQPGYEDRVPRTPDEFAARWKASPQRAQLMQHIKSYNAKFALDGEYLDKFKQSRRAQQAKAQRVSSPYTLSYVQQVKLCLWRGYQRLKADPSVTISSLFGNTIISLVIASIFYNLKADTSTFFQRGALLFFAVLMNALGCGLEMLTLYAQRGIIEKHSRYALYHPSAEAFSSMIMDLPYKILNAITSNIVLYFMTNLRREPGAFFFFVFTSFILTLTMSMFFRSMASLSRSLVQVLPFSAVLLLGLSMYTGFAIPTGYMLGWARWIAYINPISYGFESLMINEFHNRDFPCMDYVPSGPGYTDVGLNNRVCSTVRSVPGQAFVNGNAYIESAYSYTASHKWRNIGVIFAYMFLLGAVYLVATDFITEKKPKGEILVFPRGHKALKKGKSDEDLEGGGGRSATVEKIGSDGLAMIERQTAIFQWKDVCFDIKIGKENCRILDHVDGWVKPGILTALMGVSGAGKTTLLDVLATRTTMGIISGEMLVDGQPRDESFQRKTGYAQQQDLHLSTATVREALEFSALLRQSAHVPRQEKIDYVTEVIKLLDMTEYADAVIGVPGEGLNVEQRKRLTIGVELAARPQLLLFLDEPTSGLDSQTSWAILDLLDKLKKNGQAILCTIHQPSAMLFQRFDRLLFLQAGGRTVYFGEIGQNSQILIDYFVRNGAPPCPPDANPAEWMLDVIGAAPGSHTSINWFETWRRSPEYARVQEHLAELKHERRHQTNLFRTTSGQKREDKDSYREFAAPFWAQLYQVQVRVFQQIWRSPTYIYSKTALCVLSALFVGFSLFHTPNTIQGLQNQMFGIFMLLTLFGQLIQQIMPHFVAQRALYEVRDRPAKTYSWKAFLIANIVVELPWNSLMSVLMFLCWYYPIGLYRNAEPTDAVHLRGTQMWLMIWTFLLFSSTFAHFMIAAFDAAENAGNLGNLLFLLCLLFCGVLATPDQLPRFWIFMYRVSPFTYLVSGMLSVGISNTNVTCADNEYLRFDPVNGTCGEYMGSYMSNLGGYLADEMATANCSFCPIKETNVFLGRVSSSYSDIWRNFGLMWVFIVFNIFAACSLYWWVRVPRDKKPVAKAE	5.03	gnl|BL_ORD_ID|2167|hsp_num:0	2416			2487	2538	methicillin; daptomycin; cefotaxime; moenomycin A1
BGC0001433.1|Argimycin_23 # 55828 # 56367 # -1 # ID=1_23;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.706	BGC0001433.1|Argimycin_23 	55828	56367	-	Loose	525	29.261	LEN-12	36.17	3002462	protein homolog model	n/a	n/a	penam; penem	antibiotic inactivation	LEN beta-lactamase	GTGATCCGCTCGATCGAGAGAAACGGAGTCCGTGGCATGGCGGAGAGCCGACTGGCCTTCCGGGCCGTGGTGCCGGGCGACAGGACAGCACTGGAACGCATGCACCGCAGATGCAGCGAGGCGACGCGGTACCACCGTTTCCAGACCAGGGGTCCCGGCCTGCCCGAGAGCTACCTGGACACCGTGTTGGGCGAATCCGCGGGCGTGACCAGCATCCTGGCGACCGACGGCCCGCCGGACCGCCGCCGGGTCGTCGCGCTGGCCAGCATGGCCCCCGTCTCGCCCGGTGTCGCGGAGCTGGGCATCCTCGTGGAGGACGGCTGGCAGCGCCGGGGTGTCGGCCGGCTGCTCGTACGCCAACTGGTCGGTGTCGGCCGGGCCCAGGCTCTGCACGCGCTCACCGCGCAGACGCTCACCACTCGCCGGTGGATTCTCGGGCTGCTCCGGGACGAGGTGGGAGGAGCCGTGTCGTACGGCCCCATGTCCGACACCGTCAGGATCACGGCGTTCCTGGAACCGGTTGGTGAGAGGTGCGGGTGA	MIRSIERNGVRGMAESRLAFRAVVPGDRTALERMHRRCSEATRYHRFQTRGPGLPESYLDTVLGESAGVTSILATDGPPDRRRVVALASMAPVSPGVAELGILVEDGWQRRGVGRLLVRQLVGVGRAQALHALTAQTLTTRRWILGLLRDEVGGAVSYGPMSDTVRITAFLEPVGERCG	MRYVRLCVISLLATLPLAVYAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADERFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCAAAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPASMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGARGIVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR	62.59	gnl|BL_ORD_ID|963|hsp_num:0	1051			717	858	
BGC0001433.1|Argimycin_24 # 56368 # 56634 # 1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.614	BGC0001433.1|Argimycin_24 	56368	56634	+	Loose	500	22.7126	SMB-1	31.25	3000854	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	SMB beta-lactamase	ATGCGACGCAGCCCTGCGAGACGGCGCCCATGGCTGTGCGTGTGCCTGCACCGAGCCCTGTCCCCGTGTCCAGCAATTTTCCTCCGCAAGTACAACCCAGAATCTGCTGAACAGCACCTCTCGCCGTATGGGACGTTGGTCCTATTGATCGGCAACTGGGAATCCTGCCAGGCTGGCCCGCCATGGACGCAGCACAGCAGGAGATTCTCTACAATCCCCGTGATCCTGGGATGCGCAGCGACCCCTATCCTTTCTACGCCCGGCTGA	MRRSPARRRPWLCVCLHRALSPCPAIFLRKYNPESAEQHLSPYGTLVLLIGNWESCQAGPPWTQHSRRFSTIPVILGCAATPILSTPG	MKIIASLILAAFASVAQAQDRDWSSPQQPFTIYGNTHYVGTGGISAVLLSSPQGHILVDGTTEKGAQVVAANIRAMGFKLSDVKYILSTHSHEDHAGGISAMQKLTGATVLAGAANVDTLRTGVSPKSDPQFGSLSNFPGSAKVRAVADGELVKLGPLAVKAHATPGHTEGGITWTWQSCEQGKCKDVVFADSLTAVSADSYRFSDHPEVVASLRGSFEAVEKLSCDIAIAAHPEVNDMWTRQQRAAKEGNSAYVDNGACRAIAAAGRKRLETRLASEKR	31.43	gnl|BL_ORD_ID|751|hsp_num:0	753			453	549	
BGC0001433.1|Argimycin_25 # 56598 # 57770 # 1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.662	BGC0001433.1|Argimycin_25 	56598	57770	+	Loose	700	25.7942	MOX-9	29.31	3002191	protein homolog model	n/a	n/a	cephalosporin; cephamycin; penam	antibiotic inactivation	MOX beta-lactamase	ATGCGCAGCGACCCCTATCCTTTCTACGCCCGGCTGAGGGAAACCGAGCCGGTGCACCTGACGCCGTACGGCTTCTGGGTGGTTTCCGGCTACAAGGAGACCGCATCTCTCCTCCGGGACAACCGGCTGACCAGCGAGTTCCATCGTGACCCGAAATGGGCCGAGCACCGTGGTGGCTGGGAAAGTCCGGTGGTCAAGGACACCCGAATGTGGATGCTCATGCTGGACGGTGCCGCTCATCGCCGTATTCGCGGAATCGTCAACCCGGTATTCAGTGCCCGGTCGATCCACCAGATGGTCCCGAAGATCGAGGAGATCCTCGAACGCATCCTGGCCGACCTCGGTTCGGGCGAGGGGATCGACCTCATCGACTCGCTCGCACTGCCACTCCCGGTGACCGTCATCTGCGGCCTCGTGGGACTGCCGGTCGAGGACCGCGACCAGTGCCGTCAGTGGACCGAGGCGATAGGCCACGTGGTCGACCCCGCGCTGAGCGAGGAGACCCAGCAGCGCATGAACACCGCCCTGGTGGAGTTCCGCGCGTACATCACCGAGCACTTGGCCAAGCGGCGCAGCGACCCCCAGGACGACATCCTGTCCCGGTTGGCCTTCGCCGAGGTGGACGGCGAACGCCTGTCCGACGACGAGATCGTCGCCAACGTCCTGCTCCTGTTCAACGCGGGGCACGAGACCACGGTCAACCTGATCGGCAACGGCATGCTGGCGCTGCTCAGGAACCCCGACCAGCTCCAGATCCTGCGAGACCACCCCCAACTGGTCGACAACGGCATCGAGGAGTTCGTCCGGTACGACGCCCCCGTGCAGCTGGTCGCGCGTATCGCCACCGCCGACCTGGAGGTGGGCGGCAGGACCATCCCCGCGGGTTCCAAGATCATGCTCCTGCTCGGTGCCGCCAACCGCGATCCGAGGCGGTACGCGCACGCCGACCGGCTGGACGTGCGCCGGGACGACATCAAGCCGCTGTCGTTCGGCGGCGGACCGCACTTCTGCATCGGCACCATGCTCGGCAAGATGGAAGGGCGCCTGGTCTTCCGCGAGTTGCTCGACCGGTACAGCCAGATCTCGCTCACCACCGAGGACGTCGTCTGGCGGCCACACGTCAACTTCCGCGGCCTGAGCGAACTGCGGGTGGATCTCGTCCACAGCAGCTGA	MRSDPYPFYARLRETEPVHLTPYGFWVVSGYKETASLLRDNRLTSEFHRDPKWAEHRGGWESPVVKDTRMWMLMLDGAAHRRIRGIVNPVFSARSIHQMVPKIEEILERILADLGSGEGIDLIDSLALPLPVTVICGLVGLPVEDRDQCRQWTEAIGHVVDPALSEETQQRMNTALVEFRAYITEHLAKRRSDPQDDILSRLAFAEVDGERLSDDEIVANVLLLFNAGHETTVNLIGNGMLALLRNPDQLQILRDHPQLVDNGIEEFVRYDAPVQLVARIATADLEVGGRTIPAGSKIMLLLGAANRDPRRYAHADRLDVRRDDIKPLSFGGGPHFCIGTMLGKMEGRLVFRELLDRYSQISLTTEDVVWRPHVNFRGLSELRVDLVHSS	MQQQVRMTLLMASTLLWAGLAQATADTQADPLRPLVDASIRPVLKEHRIPGMAVAVLKDGKAHYFNYGVANRESGARVSEQTLFEIGSVSKTLTATLGAYAVVKGALKLDDKVSQHGPWLKGSAFDGITMAELATYSAGGLPLQFPDEVDSIDKMRAYYRQWTPAYRAGSHRQYSNPSIGLFGHLAAQSLGQPFEQLMSQTLLPGLGLEHTYLKVPAEAMANYAYGYSKEDKPIRVNPGVLADEAYGIKTSSADLLKFVGANMTGTGDEAMQQAIALTHKGVYSVGAMTQGLGWESYAYPVTEETLLAGNSGKVILEANPTAPASNETGSQVLFNKTGSTGGFGAYVAFVPAKGIGIVMLANRNYPIQARVETAHAILSKLAE	101.83	gnl|BL_ORD_ID|2100|hsp_num:0	2329			123	297	
BGC0001433.1|Argimycin_26 # 57824 # 59488 # 1 # ID=1_26;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.703	BGC0001433.1|Argimycin_26 	57824	59488	+	Loose	1000	59.3066	almE	24.51	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	TTGTCCGGTGACACGCTCACCGAGAACTTCCTGCACCACACACAGGCGTCACCGGCTGCGGCAGCGGTTTTCCCCGGCAGCGACGAGCGGATCACCGCCGGCGAGCTGGCCGAGGCCACTCTGAGCTGCGCACTGGGGCTCCGGGAACACGGCGTGGGCCCCGGCTCGATCGTCGGTCTCCTGGTGCCCACCGACGCGAGGTTCCTGACCCTCTTCTTCGGCGTGCAGCGCACCGGAGCCGCGTGCAGCGTCCTCCCGCTGCCCGCGGGATTCGGCGACGAGCGGGCCACCGCACGGAGGCTGAGCAGGATTCTCCAGGTCGCGGGTATCCGCCACCTGGTGCTCGGCCCGGCCTACGCCGACCTGGGCTCTCTCCTCATGGAGCAGAACCCGGGGCTGATGCTGATCGACCCGGGTACGTCCCGTTCCGGTAGCGCCCGCGCCCTGCCCCCGGTGGACCCGGACGCCCTGTCCGTCGTGCAGTTCACCTCGGGCAGCACCAGCGCTCCCAAGGGCGTACAGCTCAGCCAGCGGTCCATGGCCGCCGGTCTGCGCGCCTGTGTGGTGTCCGGCGCCTTCAGTCCCGACGACGTCTTCATGCAGTGGGTGCCCACCTTCCACGACATGGGGCTCGTGGGCCTCTTCTCTCACCTGCTCAACGGCGCCGACGTCCACGTCTTCACCCCCACGGCTTTCCTGCGCAGGCCGGCCGCGCTGCTCAAGTACTTCGCCGAGCACCGCGGCACGGTCATCACGGGGCCGAACTTCTCGTACGACCAGATCCTCGACGCGGCTCCACCCGAGCTCGTCAGGGAACTCGACCTCTCCGCCTGGCGGCTGGCCTTCAACGGCGCGGAACCGGTGAGCGCCGCGAGCACGGAGCGGTTCACCACCGCGCTGGCACCCGCCGGAGTCCGCGACACCGTGATGTACCCGGTCTACGGCATGGCGGAAGCCACCTTGGGGATCACCTTCCCCGAGCCGGGCAGCCCCGTGCGCATCCTGTCGGTCGACCGGGCCGAACTGGCCTCGGGACGCAAGGCGGTGGTCGTACCGCGCGGCAACGAAGGCGCCAAGGACGTGGTGGGCCTCGGCCGCGCCGTGCACGGCATCGAGATCCGGCTCGTCGGCGAGGACGGCCGTGTGTGCGTGCCGGGCGAGCTGGGCGAGATCCAGATCGCCGGGCCCCCGGTGACCTCCGGGTACTACAACGACCCGCAGGCCACCGCGGCCGCCTTCGACGGCCGCTGGCTGCGCACCGGGGACGTCGGGTTCCAGTACGAGGAAAATCTGTTCGTCACCGGACGGCGCAAGGAGATGGTCATCGTCCGGGGCCAGAACTTCTTCCCCGACGACATCGAGGCCATCGCCCGCGAGATGCCGGGTGTCTACCGAAAGCGCTGCGTGGCGTTCTCCGACACGGAGCCGAACGGCAGCGAGGTGGTGCGCGTGGTGGTCGAGGCCGACCCCAGGAGCGCCGCCCCCGACCTGGCCAAGAACATCGCCGCCCGCGTCGAACAGGAGATGGACTTCTCGGACGTACGCGTGCATCTCGTCAAACCGCGCTGGATCACCCGCACCACCAGCGGCAAGTGGCAGCGATCCCTGACCCGCGAGCGGCTCTCCGAGCTGGCCTCCGCCGGACCGTCCCCGTCCGCTGACTGA	MSGDTLTENFLHHTQASPAAAAVFPGSDERITAGELAEATLSCALGLREHGVGPGSIVGLLVPTDARFLTLFFGVQRTGAACSVLPLPAGFGDERATARRLSRILQVAGIRHLVLGPAYADLGSLLMEQNPGLMLIDPGTSRSGSARALPPVDPDALSVVQFTSGSTSAPKGVQLSQRSMAAGLRACVVSGAFSPDDVFMQWVPTFHDMGLVGLFSHLLNGADVHVFTPTAFLRRPAALLKYFAEHRGTVITGPNFSYDQILDAAPPELVRELDLSAWRLAFNGAEPVSAASTERFTTALAPAGVRDTVMYPVYGMAEATLGITFPEPGSPVRILSVDRAELASGRKAVVVPRGNEGAKDVVGLGRAVHGIEIRLVGEDGRVCVPGELGEIQIAGPPVTSGYYNDPQATAAAFDGRWLRTGDVGFQYEENLFVTGRRKEMVIVRGQNFFPDDIEAIAREMPGVYRKRCVAFSDTEPNGSEVVRVVVEADPRSAAPDLAKNIAARVEQEMDFSDVRVHLVKPRWITRTTSGKWQRSLTRERLSELASAGPSPSAD	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	99.64	gnl|BL_ORD_ID|4935|hsp_num:0	5928			603	1404	colistin A; colistin B
BGC0001433.1|Argimycin_27 # 59520 # 60377 # 1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.647	BGC0001433.1|Argimycin_27 	59520	60377	+	Loose	500	28.8758	OXA-436	42.86	3003128	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGACCACTCCGCACAAGCTCCAGGCGGCCCGAGACCTCGAGACGGAACCGCTGCACAGCTACGACGTGTTCCCCGTCTACCAGAACGCCTCCTGGGAATTGAAGGACATCCCCTGGGACGAGTTCAGGCCCGACCTCGTACGCCCCGAATACATCGCCTTCGCGATGGGTGCCGTCATGGGCGAGTCCAATTCCATCGCGGCCCAGCACGGCTTCTTCAACGAGTTCGAGGACGACTACGACTTCTCGGCCTTCGTATGCCTGTGGGGCTACCAGGAGCTCCAGCACCACCTGGCCTTCAAGAAGTGGCTGCGGCTGGCCGGCGAGGACGTCGGATACGAACAGATCAACGCGATGCGGGCGCCCTACCCGCCGGGCATCACGCCCTCGGCGACCCTCGCCACGAACATCATCTCCGAGATAGCCACCAACCACATGTACAAATGCGTGAGCCGGGTGGCCGAGGAACCGGTGATCGCCAAGCTGATGAAGCGGGCGAGCGGCGACGAAGCCCGCCACGCACGGGAGTTCATCCACTACACGGCCCGGCGGCTGGTCACCCACCCGCACGAACTGGCCTCGGTACTGGAGACGTTCTACGTCTACATGGCCGACCCCGACGGGCGCTACCAGCACCCGGTGAGCAAGTTCAAGAACAACCTCCCCGAGCTCGACGGACACGTCACCATCGACGAGGTGTTCCGGTACTTCGGCGAGGTCGACGACGGCACCGAGTGGGACCGCATCCACCGTCAGCTCTTCAGCACGCTCACCGAACTCACCGGTGAGACGATCACCAGGCTGCGTGACATCCGCAGGATCCTGGCGTCGCTGCCGCCCACCCCGGCCGGCGCCTGA	MTTPHKLQAARDLETEPLHSYDVFPVYQNASWELKDIPWDEFRPDLVRPEYIAFAMGAVMGESNSIAAQHGFFNEFEDDYDFSAFVCLWGYQELQHHLAFKKWLRLAGEDVGYEQINAMRAPYPPGITPSATLATNIISEIATNHMYKCVSRVAEEPVIAKLMKRASGDEARHAREFIHYTARRLVTHPHELASVLETFYVYMADPDGRYQHPVSKFKNNLPELDGHVTIDEVFRYFGEVDDGTEWDRIHRQLFSTLTELTGETITRLRDIRRILASLPPTPAGA	MRALALSAVLMVTTMIGMPAVAKEWQENKSWNAHFSEHKTQGVVVLWNENTQQGFTNDLKRANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIAAWNRDHDLITAMKYSVVPVYQEFARQIGEARMSKMLHAFDYGNEDISGNLDSFWLDGGIRISATQQIAFLRKLYHNKLHVSERSQRIVKQAMLTEANADYIIRAKTGYSVRIEPKIGWWVGWIELDDNVWFFATNMDMPTAEGLGLRQTITKAVLKQEKIIP	107.55	gnl|BL_ORD_ID|2485|hsp_num:0	2876			201	327	cloxacillin; oxacillin; cefalotin
BGC0001433.1|Argimycin_28 # 60377 # 60889 # 1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.688	BGC0001433.1|Argimycin_28 	60377	60889	+	Loose	2200	25.0238	rpoB2	38.64	3000501	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	ATGACGACCGAGGCCACTCCGGTCAAGCTGCCCTGGATCGACGAGCCCCGCTTCCAGTGCTTCGGCTGCTCGCCGCGGAACAAGATCGGTCTCGCCCTGAAGATGTACCGGACCGACGACGGCGGCCTCGCCACCGACATCACCTTCGCCGACGACTACGCGTCCTATCCCGGAGTGGTGCACGGCGGGATAGTCAGTGTGCTGGTCGACGAGCTGATGGGCGACCTGATCGCCCTGGACCGCGGCCTGCTGGCGTTCTCCGTGACCCTGCGCACCAAATTCCTGCGGCCCCTGCGCACCGGCACGCCCTACCGGGCCGTCGCCCGTGTCGTGCGCGAGGGGGCCGGGGTCGTACACGCGGAGGCCGACGTCCTCTCGTCGGACGGTGAACACCACGTCATGGCGAGCTCCGCCTACCAGCCGATCAGCTCGGAACAGGCGACGGGGCACATGGGCCTGGCCGGCGCCGACCGGGACCGGCTCGCCCACTACTTCGACCACTCGATTGGATGA	MTTEATPVKLPWIDEPRFQCFGCSPRNKIGLALKMYRTDDGGLATDITFADDYASYPGVVHGGIVSVLVDELMGDLIALDRGLLAFSVTLRTKFLRPLRTGTPYRAVARVVREGAGVVHAEADVLSSDGEHHVMASSAYQPISSEQATGHMGLAGADRDRLAHYFDHSIG	MLEGRIVTVSSRTESPLAAPGVPGAPRRLSFARIREPLAVPGLLDIQTESFGWLIGAPDWCARAAARGTEPVAGLAEVLAEISPIEDFAGTMSLTLSDPRFEEVKASVEECKDKDLTYAAPWFVTAEFVNNNTGEIKSQTVFMGDFPMMTAHGTFVVNGTERVVVSQLVRSPGVYFDHAIDKGSEKDVHSARVIPSRGAWLEFDVDKRDTLGVRIDRKRRQPVTVLLKALGWSAERIAERFGFAPLIMASLAKDNVAGTDDALLEIHRKLRPGEPPTKESAQNLLANLFFTEKRYDLARVGRYKIDKKLGLRAPGAPRVLTEDDIAATIEYLVRLHAGERTMIAPGGVEVPVEVDDIDHFGNRRVRTVGELIQNQIRVGLSRMERVVRERMTTQDVEAITPQSLMNIRPVVAAMKEFFGTSQLSQFMDQRNPLASLTNKRRLSALGPGGLSRERAGLEVRDVHYSHYGRMCPIETPEGPNIGLMGYLSVYARVNPFGFVETPYRRVVDGRVTDEVDYLTADEEDRHVVAQANEPLDAEGRFLAARIPVRRKNSEVELVDSAAVDYMDVSPRQMVSVATAMIPFLEHDDANRALMGANMQRQAVPLIRSEAPIVGTGMELRAAVDAGDVVVNEKAGVVEEVSADYVTVMADDGTRKSYRMRKFNRSNQGTCSNQRPIVDEGQRVEAGQVLADGPCTENGEMALGKNLLVAIMPWEGHNYEDAIILSQRLVEQDVLTSIHIEEHEIDARDTKLGAEEITRDIPNVSDEVLADLDERGIVRIGAEVRDGDILVGKVTPKGETELTPEERLLRAIFGEKAREVRDTSLKVPHGESGKVIGIRVFSREDDDDLPPGVNELVRVYVAQKRKIQDGDKLAGRHGNKGVIGKILPTEDMPFLPDGTPVDIILNTHGVPRRMNIGQILETHLGWIGKAGWKVEGNPEWAKDLPEEMWEAPADSNIATPVFDGAREEELTGLLGSTLPNRDGERMVDDNGKAVLFDGRSGEPFPYPVAVGYMYILKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMECWAMQAYGAAYTLQELLTIKSDDVVGRVKVYEAIVKGDNIPEPGVPESFKVLLKELQALCLNVEVLSAGAAVELAHGVDDDHERTAANLGINLSRAESITETELSG	14.63	gnl|BL_ORD_ID|2431|hsp_num:0	2831			1500	1614	rifampin; rifaximin; rifabutin; rifapentine
BGC0001433.1|Argimycin_29 # 60886 # 61176 # 1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.674	BGC0001433.1|Argimycin_29 	60886	61176	+	Loose	300	24.6386	dfrK	22.67	3002869	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	ATGACCATGACTCAGTCCGCCGACCACCGGCTCTCCGCTCTCGACGCCACCGCGGTCCTTGACGAGGTGCGAGGACAGACCAGTAAGGAACTCGGCATCGCCGTCGGCGAGATCGAGCCGGACACCGTCCTCAAGCAACTGCCCGGCTCCGACTCCGTACGGCTGCTGCGGGTCGTCGCCCAGATCGAGCGCATCTACGACGTCGAGCTGGAGGACGAGGACATCTTCGCGGTGCGCACCGCCCAGGACCTCGCCGACCTGATCCTCGCCCAGCACCGGGACGTGGCCTGA	MTMTQSADHRLSALDATAVLDEVRGQTSKELGIAVGEIEPDTVLKQLPGSDSVRLLRVVAQIERIYDVELEDEDIFAVRTAQDLADLILAQHRDVA	MKVSLIAAMDKNRVLGKENDIPWRIPKDWEYVKNTTKGYPIILGRKNLESIGRALPGRRNIILTRDKGFSFNGCEIVHSIEDVFEICNNEEEIFIFGGEQIYNLFLPYVEKMYITKIHYEFEGDTFFPEVNYEEWSEVSVTQGITDEKNPYTYYFHIYERKAS	58.90	gnl|BL_ORD_ID|1765|hsp_num:0	1913			99	321	trimethoprim
BGC0001433.1|Argimycin_30 # 61178 # 62101 # 1 # ID=1_30;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.698	BGC0001433.1|Argimycin_30 	61178	62101	+	Loose	500	26.1794	ErmD	31.58	3000495	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGACGACCGGGGTCCACAGGGAGCCCGCCCTGCTGCACACCGGCCGGGACGGAGACCTCGCCGTCCCGCCGGAGGAGGCCAGGCGCGCGACCAACCAGCACTACGAACTGCCCCCCGAGGTCTTCACGGCCTTCCTCGACGCACGCGTCAAGTACAGCTCCGCGCTGTACCGCGACCCGCACCACACCCTGGAAGAGGCGCAGACCGCCAAACTGCACTTCGTCGCCGAACGGCTCGGCCTGCGGGGCGGCGAATGCCTCCTCGACATCGGCTGCGGCTGGGGCAGCCTGACCCTGTTCATGGCCCAGGAGTACGGGTGCGAGGTGACGGCCGTCACCCCCTCCGCCCCCCAGGCGGAGTACGTCCGTGAGCAGGCGGCCCGTGCCGGGCTGAGCGGCCGCGTCATTCTCCGGATCGGGTCCTATTCGGACATGGAGGTGGAGGGCCGGTACGACGCGGCGACAATGCTGGGCTCCATCATCCACATGCCCGACCGTGTCGACGCGCTGCGCAAGACCTACCGGGCGCTGCGCCGGGGAGGGCGGCTCTACGTCTCCGAGAGCTGCTTCCGAAACGAGGAGGTCTATCAGGAATTCGCCAATCGGCCCGGCACCAAGCACGTCACGGAGCGCATCTTCGGGTTCGCCGACATGGTGCCCTTCTCCCAGCTGGTCGGAGCCACCGAGTCCGCGGGCTTCAGCCTGGAGACGCTGGACGACCTCACCGCCCACTACCACCGCACCATCGAGGAGTGGGAGCGGCGGGCACTGGCCAACAGCGACCGCATCGAGGCGGCGGCTCCGGGCATGACGGCCCCCCTGGTGGAGTACCTGCGCACGGCGAACGCCGGCTGGGGGTACACCTCGAAGCACTACGCCCTCACCGCCGTCAAGTCCCGGCTCGGGCTCAGGACCGTCCGGTGA	MTTGVHREPALLHTGRDGDLAVPPEEARRATNQHYELPPEVFTAFLDARVKYSSALYRDPHHTLEEAQTAKLHFVAERLGLRGGECLLDIGCGWGSLTLFMAQEYGCEVTAVTPSAPQAEYVREQAARAGLSGRVILRIGSYSDMEVEGRYDAATMLGSIIHMPDRVDALRKTYRALRRGGRLYVSESCFRNEEVYQEFANRPGTKHVTERIFGFADMVPFSQLVGATESAGFSLETLDDLTAHYHRTIEEWERRALANSDRIEAAAPGMTAPLVEYLRTANAGWGYTSKHYALTAVKSRLGLRTVR	MKKKNHKYRGKKLNRGESPNFSGQHLMHNKKLIEEIVDRANISIDDTVLELGAGKGALTTVLSQKAGKVLAVENDSKFVDILTRKTAQHSNTKIIHQDIMKIHLPKEKFVVVSNIPYAITTPIMKMLLNNPASGFQKGIIVMEKGAAKRFTSKFIKNSYVLAWRMWFDIGIVREISKEHFSPPPKVDSAMVRITRKKDAPLSHKHYIAFRGLAEYALKEPNIPLCVRLRGIFTPRQMKHLRKSLKINNEKTVGTLTENQWAVIFNTMTQYVMHHKWPRANKRKPGEI	106.97	gnl|BL_ORD_ID|1022|hsp_num:0	1117			105	216	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0001433.1|Argimycin_31 # 62098 # 62973 # 1 # ID=1_31;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.684	BGC0001433.1|Argimycin_31 	62098	62973	+	Loose	680	26.1794	LpeA	28.3	3004099	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAGCGCCCCCGCGCACACCGGGACGGCGGACGCGGCGACGTCCGCGGACCTCCTGCCCGTCACCCAGATGTTCGAGCTGGTGGACCACGCGGTGACGCGGGCGGGTGAGCGCGCCTGGACCCTCAACGATCTGGATTGGTCCGCGCTGCGGCCCGAGCGGCTCACCGAGGCCGACCGGTCCGCGGTCCGCTTCATCACCTTCGTCGAGGACCACATTCCCGGTTATCTCTCGCACTTCCTCGAGGCCTTCCCGGTGGCCGCCGCCGAGCAGGAGCTGGAACGGTTCGGCTTCAACCGCGAATACTTCCGCTTCCTGGTCGCCTGGGCCGGTGACGAGGAACGGCACGCCTCGGCGCTCGCGCGCTATCAGGTCGACACGGGCATGGCCACGCGCGAGGAACTGCTGACCGACCTGGCCGAGGAGGGACGCAAGACGTTCACCCTGCCCTATCAGCACCCGGTGCAGTCCTTCACGTACACGCTGATCCAGGAGAAGGCGACACAGCTCTTCTACCAGCGGTTCAGGGAAACAGTCAGCGAACCGTTCCTGAAAGACCTGCTGGGCAGGCTGGCGCGGGACGAGGCACGCCATTTCGCCTTCTACACCAACCTCGTCGGCGCCTACGTGGCGCGCGACGGAGCTGCGTCGGTGCCCGGTCTCAAGGACGTCATCGCCACGTTCCGGATGCCGCTCGCGGACACCATGAAGGGCTACTGGCGGTGGTCCCTGCGGGTCGCGGACTCCACCGCCTACGACCACACGGAGGCGTACGAGTCCGTGGTCCGGCTGGTCAGGGGCTTCGTCGACACACCGGGCGAGCCCACCGTGGCCGAGCTCGGCGAGTTCGTGCAGGCCATCCGGCGCGTGCGATGA	MSAPAHTGTADAATSADLLPVTQMFELVDHAVTRAGERAWTLNDLDWSALRPERLTEADRSAVRFITFVEDHIPGYLSHFLEAFPVAAAEQELERFGFNREYFRFLVAWAGDEERHASALARYQVDTGMATREELLTDLAEEGRKTFTLPYQHPVQSFTYTLIQEKATQLFYQRFRETVSEPFLKDLLGRLARDEARHFAFYTNLVGAYVARDGAASVPGLKDVIATFRMPLADTMKGYWRWSLRVADSTAYDHTEAYESVVRLVRGFVDTPGEPTVAELGEFVQAIRRVR	MLGIQFNRGQWRSNYYWQIPVLIIAVISILFFISKKLFYSKVTPESIPNKLVEVEPIKSHNLQQTIHLLGTIHPKHATTLIAKESGMLDTLIPTGQKVTKGTLIAKINNPDLEKNLQLSLSAVELAKAQYERITPLIKSGYVSTKEVEEKKQAWIDAQKELSKTRIELDNLRFYAPFDGIIGAYKKREGAQVNAGESVVSIYDPSALVVDFDIPCSNLATLNEGQPVYVLGKRYSLSHLQKMLDEDTHMCPADVDIQCDDCLIGATTSVELLVAEKNNTIVIPFQAIFLRNSKPFVYLVKKGKIVLASVKTGLQQEDKIEIVEGLKAGQQLVTKGQERLYPEMTVDIYHPATSSS	81.97	gnl|BL_ORD_ID|2386|hsp_num:0	2758			492	651	erythromycin; spiramycin; azithromycin
BGC0001433.1|Argimycin_33 # 63947 # 64573 # 1 # ID=1_33;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.730	BGC0001433.1|Argimycin_33 	63947	64573	+	Loose	400	25.0238	Erm(30)	41.86	3001265	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGACGATGCTCGATCCGGCCATGGTGAGGCGCGCGGTCGAGGCCACGCTCACCGAGGACGCCGCGGCCGACGGCATCACCACCCGCTGGAGTGTGCCTGAGGAGGGCCGTGCGACAGCCACCGTCTTCACCAGGAAACCGGGAGTCGTCACGGGGCTGCCCGTCGCCGTGGAGGTCTTCACCGCGATCGACCCCGAGGTGGAGACGACGCCGCAGATCAGCGACGGGACGCGCGTCGGCACGGGGGATGTGCTGCTGAAGGAGAACCACCTCATCGCGGCCGGCGGGATCAGCGCCGCCGTACGGTCCGCGCGCGCCGCCGCGGCGGAGGGGCGAACGGTGTCGGTCGAGATCGAGGTGCGCGACCTGGCTGAGGCCGAAAAGGCGCTGCGGGCTCGGGGCGACTGGACCATGCCCGACAACATGCCGCTCGACGGGATCGAGGCGGCCGTCCGGCTGCGCGACTCCCTCCCGGGGGCCCGGGAGACCGGACCCGAGAGGTCTGGCACTCCCGCACCCCGACGACTGAGGGAGCTCGCGGGGACCGGAATCAGCGCGGCTTCGGCCGGGGCGCTGACACACAGCGCCCCGGCGCTGGACCTCAGCACGCGGCTGGAGGCGGGGTGA	MTMLDPAMVRRAVEATLTEDAAADGITTRWSVPEEGRATATVFTRKPGVVTGLPVAVEVFTAIDPEVETTPQISDGTRVGTGDVLLKENHLIAAGGISAAVRSARAAAAEGRTVSVEIEVRDLAEAEKALRARGDWTMPDNMPLDGIEAAVRLRDSLPGARETGPERSGTPAPRRLRELAGTGISAASAGALTHSAPALDLSTRLEAG	MAMRDSIPRRADRDTLRRELGQNFLQDDRAVRNLVTHVEGDGRNVLEIGPGKGAITEELVRSFDTVTVVEMDPHWAAHVRRKFEGERVTVFQGDFLDFRIPRDIDTVVGNVPFGITTQILRSLLESTNWQSAALIVQWEVARKRAGRSGGSLLTTSWAPWYEFAVHDRVRASSFRPMPRVDGGVLTIRRRPQPLLPESASRAFQNFAEAVFTGPGRGLAEILRRHIPKRTYRSLADRHGIPDGGLPKDLTLTQWIALFQASQPSYAPGAPGTRMPGQGGGAGGRDYDSETSRAAVPGSRRYGPTRGGEPCAPRAQVRQTKGRQGARGSSYGRRTGR	61.90	gnl|BL_ORD_ID|1123|hsp_num:0	1224			873	1002	narbomycin; methymycin; pikromycin
BGC0001433.1|Argimycin_35 # 64998 # 65441 # -1 # ID=1_35;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.651	BGC0001433.1|Argimycin_35 	64998	65441	-	Loose	400	23.483	MAB	30.23	3007180	protein homolog model	n/a	n/a	cephalosporin; penam; penem	antibiotic inactivation	class A Mycobacterium abscessus beta-lactamase	TTGATCACGGGCGAAGTCGTTGCCCCTCCCGTCGCCCAGGTGCTCGGTATCTCCGTCACCAAGGTGGATCCAGGTGCGGTGCAGTTCACCATGCCGGTCAAGAACTTCTTCACCAACCATCTGGGGTTTCTTGCCGGCGGTATCCTGTCCACTGTCATTGACTCCGCCCTGGGCTGCGCGATTCTCTCCGCGATTCCGGACGACAAAGACATCGTCACGCTCGACCTGAGCGTCGACTTCCTGAGGCCGGTCTCTGAAGCCTCCGGCCTGATCACCGTGGACGCTGAGGTCGTCCACCTGGGACGCTCACGCGGTCTGGCCGCCTGCCGTGCCGTGGACTCGGCCGGCAAACTGTGTGCCGTCGGCAAGAGCAGCTGCATGGTGCGGGACAAGCCGAAGGCGCCGGCCAATGGCCACGCGCCCGCGGCGGGGGTCTCCCGGTGA	MITGEVVAPPVAQVLGISVTKVDPGAVQFTMPVKNFFTNHLGFLAGGILSTVIDSALGCAILSAIPDDKDIVTLDLSVDFLRPVSEASGLITVDAEVVHLGRSRGLAACRAVDSAGKLCAVGKSSCMVRDKPKAPANGHAPAAGVSR	MISRRALLVGGVSAVGVVAAGCSRNGNRRPAPDELASLEKDFGGRIGVYALDTGSGDTVGHRADERFLMCSTVKTFIVSAILRRRLSEPGLLDQRIQYTQSDVLEWAPITSQHVSTGMTVSELCDATLRYSDNTGANLLITQLGGPKETEKFVRSLGDNVTRMDRTEVQLNIPDGDLDTSTPQQLVANLRRLVLDEGLDSRGRDLLTDWLKRNTTGDQSIRAAVPAGWTVADKTGGGFKGETNDIAVIWPPGRAPIVMAVLTVPEDPTSTKGKPTIAAATRIVLRAFGA	50.87	gnl|BL_ORD_ID|4810|hsp_num:0	5799			465	594	ceftazidime; cefuroxime; amoxicillin; cefalotin; ticarcillin
BGC0001433.1|Argimycin_36 # 65813 # 66814 # 1 # ID=1_36;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.685	BGC0001433.1|Argimycin_36 	65813	66814	+	Loose	400	28.1054	Erm(43)	32.43	3003205	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGACAGCAAGGCTACAATCCGCAAACCGATTCTTCGCCAGCCCTCTCGGATTGGGCGCCTACCGACCCGGTCGCGTCGTGGACAACGCAGAGATCTGTCGACTCATTGATTCGGACACCGATTGGATCGAGGCGCGGTCAGGAATTACTGCTCGCCGTTTCGCGGCTCCCGAGGAATCGATTCCCTTCATGGGAGCCAGGGCCGCGGAGAAGGCACTCAGCGCGGCGGGCCTGCCCCCCGCCGACGTGGACTGCGTGATCCTCGCGACGATGTCCTACCTCCACCAGGCTCCCCCCGCGGCCGCGGCCTGTGTCGCCGAGCTGGGCGCGGACGGTGCGGCAGCTTTCGACCTCGGCGCGGCATGCGCGGGCTTCTCCCATGGACTGGCGCTGGCCGGCAGCCTCGTGGTGGCGGGCCAGGCGGAGCACGTGATGGTGATCGGCGCGGAGCGCATGAGTGACATCGTCGATCCACGGGACCGGTCAACCGCCTTCATCTTCGGCGACGGCGCGGGCGCCATGCTCGTGGGACGCTCCGCCGAACCGGGCATCGGCCAGGTCGCGTGGGGCACGGCGACAGGCCATATACGAGCCATTCAGCAGCCCGCGTCGTTCGCGGACCTGAAAGGCGGAGCATCCGCGCCGTGGCCCTACTTGGAGATGGCCGGCCCCGAAGTCTTCCGGTGGGCGATAGGTGCCGTCGGCGAGGTGTGCTCACGCGCCCTGGAATCGGCGGGAGTGGACAGCGGAGACATCGAGGCGTTCGTGCCCCACCAGGCCAATGGCCGCATCATCGACGCCGTGGTCAAGAACATGAAGCTGCCCGCTTCGGTGGCGGTGGCGCGCACGATCCGGGAGGACGGCAACACCTCGGCCGCGTCCGTACCGCTCGCGATGGATCATCTGGTGTCAACCGGCCAGGTCCGGCGCGGTGGCCTCGCCCTGACCGTGGGGTTCGGCTCGGGGCTCGGCTACTCGGCCCAGGTGATCACGGTTCCCTGA	MTARLQSANRFFASPLGLGAYRPGRVVDNAEICRLIDSDTDWIEARSGITARRFAAPEESIPFMGARAAEKALSAAGLPPADVDCVILATMSYLHQAPPAAAACVAELGADGAAAFDLGAACAGFSHGLALAGSLVVAGQAEHVMVIGAERMSDIVDPRDRSTAFIFGDGAGAMLVGRSAEPGIGQVAWGTATGHIRAIQQPASFADLKGGASAPWPYLEMAGPEVFRWAIGAVGEVCSRALESAGVDSGDIEAFVPHQANGRIIDAVVKNMKLPASVAVARTIREDGNTSAASVPLAMDHLVSTGQVRRGGLALTVGFGSGLGYSAQVITVP	MNNKNPKDTQNFITSKKCINEILKNIIITADDNIVEIGTGKGHFTKALSKVVKSVIGVEIDKSLYYNLKKDSKLQDNIQLINQDILNFQFPDNKDYKIFGSIPYNISTEIIKKILYESKAEYNYLIVELGFAKRIQDKNKALSLLLLPKMDVEILKVIPNKYFHPKPKVESALILLKKHKPLISAKDEKNYQFFVYKWVNKEYKKLFTKNQFKKALKNANVQNLNKISKQQFISIFYSYKLFN	137.04	gnl|BL_ORD_ID|1422|hsp_num:0	1546			411	522	erythromycin; clindamycin; pristinamycin IA
BGC0001433.1|Argimycin_37 # 66801 # 66983 # -1 # ID=1_37;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.760	BGC0001433.1|Argimycin_37 	66801	66983	-	Loose	450	22.7126	ANT(4')-Ib	41.18	3003905	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(4')	ATGGGGCCGCACATCACGGGACCCGCGACCTCCGCCCGGCGCGGCCGGATGCGGACGTGCGGCGCGGCCTGCGCCGAGGGCGGGGCGAGGTGCGCGACGTCCGTTCCTTGTTCTGACGCGCTCGGCCTGCCGGGCGGTGGCCGGGCCGGCCGGCGGAGCTTCGGGTATTTCAGGGAACCGTGA	MGPHITGPATSARRGRMRTCGAACAEGGARCATSVPCSDALGLPGGGRAGRRSFGYFREP	MNMNGPASMAQKERLQTCQEIAKRLHEVYGNDVLAIGVYGSVSRGTDGPFSDIEMFCVLRDSAETVDKSYEWSAGPWKAEVNVCSASILLKDAATVEDRWPLTHGPYFSPLRLYDPEGFFQRLRLAAESPTKEDFRQAIHEILVGEMYEYVGKLRNVNRNGPSTYLPSLALRFAHYGAMLIGLHNQTLFSTGAMVLPEALKLPHRPKGFDHVAELAMSGDLAQPAKIVSACEDFWKGLVAWAAEHDYVIHSKRIPF	23.44	gnl|BL_ORD_ID|2143|hsp_num:0	2383			3	54	dibekacin; amikacin; tobramycin; isepamicin
BGC0001433.1|Argimycin_38 # 66983 # 67456 # -1 # ID=1_38;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.601	BGC0001433.1|Argimycin_38 	66983	67456	-	Loose	700	25.7942	Staphylococcus aureus norA	33.93	3004667	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	AGGCCCAACACGCTGGCGGAGAGATTGAATCACCTGTTTGAGACGGTCCATCCTCGCGGTCGTGGCCCCTACAGCAACGAGGAGGTGGCGCGCGCGATCCGGGAGCAGGGTGGTGACATCTCGAAGCAGTACATCGCCTATCTCCGGAAGGGTGAGAGGGAGAACCCGCGAGTGCACCATTTGGAGGCACTTGCCCGATTCTTCGGTGTTCAGGTCTCCTACTTCATCGACAGTGAATCCGCGGAACGCACCAAAGAAACGCTCGCGGAGCTCGCGGTCTGGCGCGACAGCGGACTCACCGGTGAGGATCTGCGCAAACTTGAGAAGGCGGGCATCACGCGAGTGGCCATGCGTGCGGTGGGGCTTTCTCCGAAGGGGCTGGAATTCGCGGAAGTCATGCTGGACCAACTGCGGGAAATGGAAGGGCTGCGTTCGCAGGAAATTTCCGAGAACAACTCGAACGACGAGGCGTGA	RPNTLAERLNHLFETVHPRGRGPYSNEEVARAIREQGGDISKQYIAYLRKGERENPRVHHLEALARFFGVQVSYFIDSESAERTKETLAELAVWRDSGLTGEDLRKLEKAGITRVAMRAVGLSPKGLEFAEVMLDQLREMEGLRSQEISENNSNDEA	MNKQIFVLYFNIFLIFLGIGLVIPVLPVYLKDLGLTGSDLGLLVAAFALSQMIISPFGGTLADKLGKKLIICIGLILFSVSEFMFAVGHNFSVLMLSRVIGGMSAGMVMPGVTGLIADISPSHQKAKNFGYMSAIINSGFILGPGIGGFMAEVSHRMPFYFAGALGILAFIMSIVLIHDPKKSTTSGFQKLEPQLLTKINWKVFITPVILTLVLSFGLSAFETLYSLYTADKVNYSPKDISIAITGGGIFGALFQIYFFDKFMKYFSELTFIAWSLLYSVVVLILLVFANGYWSIMLISFVVFIGFDMIRPAITNYFSNIAGERQGFAGGLNSTFTSMGNFIGPLIAGALFDVHIEAPIYMAIGVSLAGVVIVLIEKQHRAKLKEQNM	40.46	gnl|BL_ORD_ID|2206|hsp_num:0	3367			90	246	enoxacin; ciprofloxacin; norfloxacin; ofloxacin
